(11324,11324,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:34','2024-05-24 14:52:34','6223a753-3233-468e-9b5a-d483b59514da'),(11325,11325,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:36','2024-05-24 14:52:36','441c2acc-f71a-4cde-b798-3e49e061e869'),(11326,11326,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:36','2024-05-24 14:52:36','4a45bc37-1cc0-42e5-bc42-942af9a3d969'),(11327,11327,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:36','2024-05-24 14:52:36','7ea368ba-f21e-4f64-8ba0-5478c4fa8451'),(11328,11328,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:36','2024-05-24 14:52:36','b3463ed1-2854-4b0d-99ba-af4548a92b3c'),(11329,11329,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:36','2024-05-24 14:52:36','6806cf3a-4a3d-43ad-803e-c90096d10baf'),(11330,11330,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:36','2024-05-24 14:52:36','b31557c3-2835-4bb4-9825-7071b678fd43'),(11331,11331,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:38','2024-05-24 14:52:38','dad1f045-1e21-4fb4-a6da-63ef7b95ea8b'),(11332,11332,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:38','2024-05-24 14:52:38','f4cfc9de-433e-4a66-9058-59cebeaad4b2'),(11333,11333,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:38','2024-05-24 14:52:38','5906f64e-7fc4-484c-a790-33aebdb918d2'),(11334,11334,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:38','2024-05-24 14:52:38','48671792-3445-4f43-9d64-704fc5c80f37'),(11335,11335,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:38','2024-05-24 14:52:38','030ed19c-a1d5-4f12-83f2-038fbb9656ad'),(11336,11336,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/publichealthgateway/healthdirectories/healthdepartments.html\"}',1,'2024-05-24 14:52:38','2024-05-24 14:52:38','e320eb68-79f9-48b2-b8ea-5466c305181b'),(11337,11337,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:38','2024-05-24 14:52:38','b0cfd3df-fc79-471d-a807-60c48edc41f8'),(11338,11338,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:38','2024-05-24 14:52:38','62b597dd-7f6f-4e0d-af66-d770495b7d6a'),(11339,11339,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:38','2024-05-24 14:52:38','468f788d-8f12-4e49-a3c5-ddc97eca206e'),(11340,11340,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:38','2024-05-24 14:52:38','d7d78107-4dac-4dd3-8fd4-c07926c19f23'),(11341,11341,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:39','2024-05-24 14:52:39','07976373-2b24-43ad-9b51-bd007413d1f9'),(11342,11342,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\"}',1,'2024-05-24 14:52:39','2024-05-24 14:52:39','c6e602ea-88d8-4026-9a64-38653d01d467'),(11343,11343,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:40','2024-05-24 14:52:40','68acfc0f-38a3-4e15-9bdb-1fde01d0bf87'),(11344,11344,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:40','2024-05-24 14:52:40','900fda7d-6d95-4c9f-90fe-cdf275b8d9c3'),(11345,11345,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:41','2024-05-24 14:52:41','fd6131c7-9886-48ad-9dbe-eadba3c1bd89'),(11346,11346,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:41','2024-05-24 14:52:41','6795e951-13bf-4d3d-a8c5-0760fc7bac4b'),(11347,11347,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:41','2024-05-24 14:52:41','97c2ee76-e577-458a-be5b-5773656043ad'),(11348,11348,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:41','2024-05-24 14:52:41','28767210-1fa2-4d82-80d8-3b228bc5ad4a'),(11349,11349,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:41','2024-05-24 14:52:41','99990b0e-46ae-488e-93ff-fbb940e9aafa'),(11350,11350,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:41','2024-05-24 14:52:41','3fb9d679-baa8-4215-86e1-c35ead79292a'),(11351,11351,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:41','2024-05-24 14:52:41','c98f4a78-e0d3-4a0e-9427-58edd1396d7e'),(11352,11352,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:41','2024-05-24 14:52:41','fd4d95de-a953-42ac-926f-e0975ea10efd'),(11353,11353,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:41','2024-05-24 14:52:41','735ace26-60e5-4517-b503-e71bccc3bda3'),(11354,11354,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/publichealthgateway/healthdirectories/healthdepartments.html\"}',1,'2024-05-24 14:52:41','2024-05-24 14:52:41','1cc7ddcd-ae5c-41d3-bc05-384572fbd5fa'),(11355,11355,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:43','2024-05-24 14:52:43','eba671bd-22ab-4ce8-8e2e-9f829d35698e'),(11356,11356,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:43','2024-05-24 14:52:43','2d6b99f6-62dd-4aa2-86eb-c91bee85f208'),(11357,11357,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:43','2024-05-24 14:52:43','acfdce3b-f42c-413b-a940-caffde8a5123'),(11358,11358,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:43','2024-05-24 14:52:43','f4cd87b2-47b2-4d2d-8131-3b05b4a7dcae'),(11359,11359,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:43','2024-05-24 14:52:43','33ee81ee-1c25-4ede-ab58-f6a943ce468e'),(11360,11360,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:43','2024-05-24 14:52:43','5e1ba6b8-9b74-4f5c-925c-9d726973b3f7'),(11361,11361,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:45','2024-05-24 14:52:45','04ac904e-19d9-409e-a3b8-deae02b6a463'),(11362,11362,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:45','2024-05-24 14:52:45','6cd0f014-65f1-44c0-8262-5abecc4de840'),(11363,11363,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:45','2024-05-24 14:52:45','2d5d3872-c044-4bbc-acdd-11661d62ef7c'),(11364,11364,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:45','2024-05-24 14:52:45','05308478-bc5d-4fd1-94e9-4b528ce795a3'),(11365,11365,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:45','2024-05-24 14:52:45','b041ac5f-c5ec-4e07-a8d9-d25223feebcb'),(11366,11366,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:46','2024-05-24 14:52:46','2ed97d2f-d420-489e-9717-519e19028821'),(11367,11367,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:46','2024-05-24 14:52:46','736f2a4a-a693-4494-8187-ce34667346af'),(11368,11368,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\"}',1,'2024-05-24 14:52:46','2024-05-24 14:52:46','8982a5dd-6b24-42e0-b33e-70df6661a614'),(11369,11369,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:47','2024-05-24 14:52:47','a69bd1d8-6512-499b-b5a3-fdf030a372e9'),(11370,11370,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:47','2024-05-24 14:52:47','18924f47-4a7e-46b4-839e-35b15d4d5a6d'),(11371,11371,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:48','2024-05-24 14:52:48','d304a430-987e-4b0b-8f0d-248d91284404'),(11372,11372,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:48','2024-05-24 14:52:48','093af7f0-5728-46c7-919d-1cf8e6fffe73'),(11373,11373,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:48','2024-05-24 14:52:48','7777452d-0879-42ce-9c35-8d7e20f54612'),(11374,11374,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:48','2024-05-24 14:52:48','8ab55bef-f03b-4528-aef6-887f19eca304'),(11375,11375,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:48','2024-05-24 14:52:48','b3be1939-b828-4120-b8c1-46f63c6ef079'),(11376,11376,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:48','2024-05-24 14:52:48','8caf88b1-6b64-4b6e-a19a-b02eb85ba384'),(11377,11377,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:48','2024-05-24 14:52:48','6bf35857-e88f-46ef-90e5-d14247662b59'),(11378,11378,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:48','2024-05-24 14:52:48','25997ed0-7611-4478-a062-69602f276357'),(11379,11379,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:48','2024-05-24 14:52:48','93b66e9d-c864-4df0-a579-ee8609ae392a'),(11380,11380,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"cli\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/publichealthgateway/healthdirectories/healthdepartments.html\"}',1,'2024-05-24 14:52:48','2024-05-24 14:52:48','b8f3b716-abad-4635-aea4-e6098c1b8c36'),(11381,11381,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:50','2024-05-24 14:52:50','c70628f1-809a-4d6d-a56a-881b6b855402'),(11382,11382,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:50','2024-05-24 14:52:50','a460ae33-0087-486c-a10e-da0449038f42'),(11383,11383,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:50','2024-05-24 14:52:50','bf394148-2122-4b81-a4bb-5fc2c1e85e3b'),(11384,11384,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:50','2024-05-24 14:52:50','1bbdc73e-99cc-4035-81b8-cb45bcd2fc82'),(11385,11385,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:50','2024-05-24 14:52:50','72beb34a-baa8-42b1-94c1-e1310f3abd21'),(11386,11386,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:50','2024-05-24 14:52:50','929e4bc1-56d9-47e1-b7d8-20a5a63c0a1a'),(11387,11387,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:50','2024-05-24 14:52:50','fb8d4281-78e0-476f-994c-b7a3fe87ba5c'),(11388,11388,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:50','2024-05-24 14:52:50','542c8fb9-5fb4-490c-abbc-532ac9b934cb'),(11389,11389,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:50','2024-05-24 14:52:50','b8193af9-056e-4d92-ba85-2e90c8bf851e'),(11390,11390,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/publichealthgateway/healthdirectories/healthdepartments.html\"}',1,'2024-05-24 14:52:50','2024-05-24 14:52:50','2e568ee1-e513-4d95-a315-154612e789dd'),(11391,11391,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:50','2024-05-24 14:52:50','52f930cc-c54e-4bc9-847a-3f3b92ccc8ad'),(11392,11392,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:50','2024-05-24 14:52:50','be9ba4fc-1407-475c-8627-923da36095fa'),(11393,11393,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:51','2024-05-24 14:52:51','e9f2de2f-ed46-4ae7-a2a6-014052715d77'),(11394,11394,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"P\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\"}',1,'2024-05-24 14:52:51','2024-05-24 14:52:51','c45aa1e2-f85f-416b-ac26-f65ecf436715'),(11395,11395,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:52','2024-05-24 14:52:52','758c5f07-2c41-4166-94bc-88807c549121'),(11396,11396,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:52','2024-05-24 14:52:52','5ea0d0d5-44ce-43eb-be06-4cf857cc7e0b'),(11397,11397,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:52','2024-05-24 14:52:52','411d7c90-e586-451f-9048-3dc17bd1912e'),(11398,11398,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:52','2024-05-24 14:52:52','ebb4f316-3b0a-4d65-a0d1-250c85ecfb65'),(11399,11399,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:52','2024-05-24 14:52:52','e7d4f1f7-f17c-4f0c-a745-b4566584c5cf'),(11400,11400,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:52','2024-05-24 14:52:52','a04eac43-70d2-48e6-a207-7f7d15df09d0'),(11401,11401,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:52','2024-05-24 14:52:52','3b567f6e-d40c-46c0-bc11-4abb3ad93db1'),(11402,11402,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:52','2024-05-24 14:52:52','08a87329-16e4-4d9c-ad17-fecfc97001c7'),(11403,11403,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:52','2024-05-24 14:52:52','f2e512a5-7ac9-4bf5-9c1e-77ad2ec8152e'),(11404,11404,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:52','2024-05-24 14:52:52','e3d914ac-8572-4f92-92bd-06759426a968'),(11405,11405,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:53','2024-05-24 14:52:53','9140f36d-4415-4e34-96ab-c548b80500c0'),(11406,11406,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/publichealthgateway/healthdirectories/healthdepartments.html\"}',1,'2024-05-24 14:52:53','2024-05-24 14:52:53','7088946a-505d-4c30-ae0e-daf71280d049'),(11407,11407,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:53','2024-05-24 14:52:53','a63f1913-310a-47fb-b9c5-8523a1343d4d'),(11408,11408,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health,\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\"}',1,'2024-05-24 14:52:53','2024-05-24 14:52:53','e7b98a10-82cc-4875-9942-c3b570b4cc26'),(11409,11409,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:54','2024-05-24 14:52:54','d66f1e28-017c-4b7a-a6c2-ee370139b5f8'),(11410,11410,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:54','2024-05-24 14:52:54','6ee7f839-94fe-4f77-8ad1-715705143d66'),(11411,11411,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:55','2024-05-24 14:52:55','5fb9791a-c791-4381-b996-634e90cd8c5c'),(11412,11412,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:55','2024-05-24 14:52:55','e37ad940-a0df-4f20-8a35-b546bfde60a4'),(11413,11413,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:55','2024-05-24 14:52:55','bee24db1-16c9-42ad-ba22-84567ee8852d'),(11414,11414,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:55','2024-05-24 14:52:55','85cc864e-16d6-4437-9405-0963c12f5440'),(11415,11415,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:55','2024-05-24 14:52:55','14a9ca77-25df-4352-a2ce-3b324e2f1301'),(11416,11416,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Perso\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\"}',1,'2024-05-24 14:52:55','2024-05-24 14:52:55','47f8bfc4-feb0-4445-b975-98332693261b'),(11417,11417,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:57','2024-05-24 14:52:57','e86cc51b-312c-49ac-a4e3-c78e8ebfab46'),(11418,11418,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:57','2024-05-24 14:52:57','3f800b6b-a354-4a08-882f-38c36a257878'),(11419,11419,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:57','2024-05-24 14:52:57','4d975dcf-117d-4435-8ff2-7c226cc51e91'),(11420,11420,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\"}',1,'2024-05-24 14:52:57','2024-05-24 14:52:57','d167e592-d14d-4e60-bf52-64ec4c92d673'),(11421,11421,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:58','2024-05-24 14:52:58','df65aa82-b899-4131-bc76-ce4a1e738f13'),(11422,11422,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:58','2024-05-24 14:52:58','352981d6-261a-4c27-a91c-adf301bea432'),(11423,11423,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:59','2024-05-24 14:52:59','266e2000-e320-4b68-b9af-f96be4c10c85'),(11424,11424,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:59','2024-05-24 14:52:59','27f0c920-98f9-42e4-a6a6-855eed2b64cc'),(11425,11425,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:00','2024-05-24 14:53:00','0bb31ff3-a935-48e4-87f3-afd8a0a9ec6a'),(11426,11426,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:00','2024-05-24 14:53:00','03e92343-4c7c-40f3-8cef-a0bb052570ba'),(11427,11427,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:01','2024-05-24 14:53:01','419aee71-96bd-4a64-b40a-f311afeb036b'),(11428,11428,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:01','2024-05-24 14:53:01','ebd7cadb-227d-49d4-a986-2d210a005216'),(11429,11429,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:03','2024-05-24 14:53:03','539ece50-f518-4cbc-9468-d520458bd6ec'),(11430,11430,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:03','2024-05-24 14:53:03','70fa90da-0749-445d-b844-a3af1a325360'),(11431,11431,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:04','2024-05-24 14:53:04','baacef69-47ad-456f-bb50-5401ee40b863'),(11432,11432,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:04','2024-05-24 14:53:04','1690b6da-c56a-4622-9554-83e657f1d8e6'),(11433,11433,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:05','2024-05-24 14:53:05','f8b6b058-877e-48b2-a2de-9d342c2835aa'),(11434,11434,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:05','2024-05-24 14:53:05','3ae50973-6f98-466c-bb22-75ab0ea943b7'),(11435,11435,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:07','2024-05-24 14:53:07','6e73c554-cf4c-44f7-a594-19c91b3a6583'),(11436,11436,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:07','2024-05-24 14:53:07','5fc8ed71-d698-47a9-b400-d26599860739'),(11437,11437,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:08','2024-05-24 14:53:08','5ac9fd25-e360-46d3-b885-05d3295b61b2'),(11438,11438,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:08','2024-05-24 14:53:08','537dc138-b385-4908-8c72-1f60a31bec54'),(11439,11439,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:09','2024-05-24 14:53:09','981663a0-a024-4f2f-a47c-784c4e4f22a7'),(11440,11440,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:53:09','2024-05-24 14:53:09','ce192e70-956c-4b77-af15-ef49ca7f8050'),(11441,11441,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:09','2024-05-24 14:53:09','95af101d-f563-4c24-9eb2-50ccca17b98e'),(11442,11442,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:53:09','2024-05-24 14:53:09','242ec4d9-6288-4677-9fb5-ff2d41b9546b'),(11443,11443,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:09','2024-05-24 14:53:09','ffb292b5-a2af-48f2-8db1-db0e9688906d'),(11444,11444,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/publichealthgateway/healthdirectories/healthdepartments.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website provides links to health department websites in all 50 states and the District of Columbia\"}',1,'2024-05-24 14:53:09','2024-05-24 14:53:09','b793c440-bb95-4f52-9ecb-aae51b013ece'),(11445,11445,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:09','2024-05-24 14:53:09','c48cc769-b1dc-4f5d-a751-26ffc714617e'),(11446,11446,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:09','2024-05-24 14:53:09','b8b51a22-a684-4f86-ac14-8e3b9e193a38'),(11447,11447,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:11','2024-05-24 14:53:11','fe044ab1-a53a-498e-9681-cf9922a8213f'),(11448,11448,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:11','2024-05-24 14:53:11','185b25f5-8613-4e2e-94de-c18290eb20f1'),(11449,11449,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:11','2024-05-24 14:53:11','ab2fd52c-3c29-4629-bb7a-58975faf14e9'),(11450,11450,1,NULL,'__temp_shkokwkieoofqqlgxkpwkashkduitueijbuk',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Slide Presentation: Investigating C. difficile Infections\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdph.ca.gov/Programs/CHCQ/HAI/CDPH%20Document%20Library/CDI_LHD_051717ADA.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This educational resource reviews steps for CDI cluster and outbreak response\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 14:53:11','2024-06-13 13:47:11','817ab71c-6db4-4bce-8726-9090590a5f02'),(11451,11451,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:11','2024-05-24 14:53:11','079396ca-41fb-4485-9562-136bb5408ab8'),(11452,11452,1,NULL,'__temp_utrooqtuzbuyefnwscmkzdmuguvigazymsrn',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"C. diff Guidelines and Prevention Resources\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/c-diff/hcp/resources/?CDC_AAref_Val=https://www.cdc.gov/cdiff/clinicians/resources.html\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 14:53:11','2024-06-13 13:47:11','e4d8617f-7725-42b3-9466-181b3e320849'),(11453,11453,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:11','2024-05-24 14:53:11','3821aa2d-4881-4a19-a913-c6985e781284'),(11454,11454,1,NULL,'__temp_uhpdorqbwhkekskycfhecoifvsjobfmrdwkd',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Compendium of Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/strategies-to-prevent-clostridium-difficile-infections-in-acute-care-hospitals-2014-update/D5ADD87BD88203703AF85707CE799F6E\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 14:53:11','2024-06-13 13:47:11','a157c0df-c1ad-4ac8-ab85-c5ef81b35e8e'),(11455,11455,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:13','2024-05-24 14:53:13','fe18e3a7-e73f-42e4-96dd-02cdb8f4f58b'),(11456,11456,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:13','2024-05-24 14:53:13','0a6e847d-0fa9-4b0b-b000-1a7387ec72cf'),(11457,11457,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:14','2024-05-24 14:53:14','3cccace1-85b5-4bf7-b21e-27f1ca901d0b'),(11458,11458,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:14','2024-05-24 14:53:14','8b87b87e-091a-4ae4-98f1-5dc6a051ae5e'),(11459,11459,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:16','2024-05-24 14:53:16','e35e15ae-f347-4fcc-9902-87d630b50a91'),(11460,11460,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:16','2024-05-24 14:53:16','85e62796-025b-42b0-bd2f-361e0086660c'),(11461,11461,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:17','2024-05-24 14:53:17','8e3a66be-7d08-456d-b662-0ebc11537444'),(11462,11462,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:17','2024-05-24 14:53:17','39cdac4e-87ed-475f-a0a5-e28782b373ec'),(11463,11463,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:19','2024-05-24 14:53:19','1c34b938-333a-4c76-842c-401b255502a3'),(11464,11464,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:19','2024-05-24 14:53:19','eab47ee0-ea74-435f-b8d2-888768f6a6aa'),(11465,11465,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:20','2024-05-24 14:53:20','cde13c37-6a3d-470c-b8ea-c86ed70e2560'),(11466,11466,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:20','2024-05-24 14:53:20','f87af72c-8540-48ba-a497-02cdc348b85a'),(11467,11467,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:22','2024-05-24 14:53:22','dcd97b14-9b52-4b61-ab70-0a8c06cab8f1'),(11468,11468,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:22','2024-05-24 14:53:22','c4c2b7ee-a1e2-4525-9a86-e7e66c63a365'),(11469,11469,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:23','2024-05-24 14:53:23','cad01584-10fb-4954-84fc-d0d2141be8ce'),(11470,11470,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:23','2024-05-24 14:53:23','e0f1da0a-ca59-4594-bbc5-e0c0931792f9'),(11471,11471,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:25','2024-05-24 14:53:25','f17358e7-1ee5-402f-9b33-880b081d48db'),(11472,11472,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:25','2024-05-24 14:53:25','ca9bb0db-9495-42a2-b426-fdd8f63a37a9'),(11473,11473,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:27','2024-05-24 14:53:27','1d64c229-31ba-472f-9a4a-06651357a1d7'),(11474,11474,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:27','2024-05-24 14:53:27','da5f70e7-4af3-4df6-a121-de0441cc81bd'),(11475,11475,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:27','2024-05-24 14:53:27','55d2fa44-a0c4-4991-9ed3-ef8445168a7f'),(11476,11476,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:27','2024-05-24 14:53:27','986ebc0b-ee3a-4965-8395-005087717590'),(11477,11477,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:27','2024-05-24 14:53:27','931a099b-b9f0-4b64-adc5-ac06210bee24'),(11478,11478,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\"}',1,'2024-05-24 14:53:27','2024-05-24 14:53:27','3d1d1deb-e44e-4eb2-af9b-e757afdd53b7'),(11479,11479,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:29','2024-05-24 14:53:29','7862e836-de84-4c82-9ac6-584a997cc4c8'),(11480,11480,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:29','2024-05-24 14:53:29','6d6381db-073a-4ab6-9e08-82a3e1a8361d'),(11481,11481,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:30','2024-05-24 14:53:30','0e007a28-e027-42c1-a17b-e1c48c752756'),(11482,11482,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:30','2024-05-24 14:53:30','b2004a13-95d2-42d4-afc0-e5fff5d862b0'),(11483,11483,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:30','2024-05-24 14:53:30','66539c13-c89f-4e64-bc9d-caf559261e12'),(11484,11484,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:30','2024-05-24 14:53:30','3ffa274a-cd0c-403f-9e33-aa70e6442392'),(11485,11485,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:32','2024-05-24 14:53:32','ccb9b0e0-64a4-438e-9c4b-a36dab02ff05'),(11486,11486,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:32','2024-05-24 14:53:32','dffdc035-1868-4e4e-8197-e6290f748d9b'),(11487,11487,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:32','2024-05-24 14:53:32','f9e92949-c106-4927-9daa-a59f6eee6f63'),(11488,11488,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:32','2024-05-24 14:53:32','4be3b53a-3b72-4759-b9e4-61d516b95110'),(11489,11489,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:33','2024-05-24 14:53:33','b32a49b6-633d-46b6-bb0a-823443849ba9'),(11490,11490,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:33','2024-05-24 14:53:33','496f3336-60f4-4577-9388-a45f86ac739c'),(11491,11491,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:34','2024-05-24 14:53:34','e914fc7f-f242-45d8-bf6f-6191caed1d13'),(11492,11492,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\"}',1,'2024-05-24 14:53:34','2024-05-24 14:53:34','b162de77-8ea1-499c-8b16-da4b6e232407'),(11493,11493,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:36','2024-05-24 14:53:36','922cec6e-13fd-48f6-a783-81ed66c64760'),(11494,11494,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:36','2024-05-24 14:53:36','f5c6da2c-aa5e-41fd-bbe5-218c5a26d75e'),(11495,11495,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:36','2024-05-24 14:53:36','b75540d8-3e26-465d-ae49-5263e8cba961'),(11496,11496,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:37','2024-05-24 14:53:37','4ca83512-1aac-4f2c-8a47-268478f91942'),(11497,11497,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:37','2024-05-24 14:53:37','e811a555-e539-470d-95c5-f6b4dbe24dab'),(11498,11498,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:37','2024-05-24 14:53:37','fbd836d8-2e64-4d83-8e7f-7c1edd9f9c47'),(11499,11499,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:37','2024-05-24 14:53:37','ba772235-43f7-40cf-8955-35d58fef7c2f'),(11500,11500,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\"}',1,'2024-05-24 14:53:37','2024-05-24 14:53:37','3e5f684f-dbb3-4a2d-96cc-cdfba04a56c4'),(11501,11501,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:38','2024-05-24 14:53:38','7f419cea-a6a8-477b-ac9c-dc96e11632d5'),(11502,11502,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:38','2024-05-24 14:53:38','086322ce-806e-4e55-b911-dd93f6e655bc'),(11503,11503,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:39','2024-05-24 14:53:39','58893ba4-fbb6-4798-8ae3-421e43475187'),(11504,11504,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:39','2024-05-24 14:53:39','3b3538b1-a3a2-4b12-9f8b-769ed17b74b6'),(11505,11505,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:39','2024-05-24 14:53:39','0c02ebfa-cb5a-49d8-b7cf-b7511bb41c80'),(11506,11506,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:39','2024-05-24 14:53:39','c8c07be3-12b0-4c67-87bf-f1fb9ca9330d'),(11507,11507,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:41','2024-05-24 14:53:41','0724bac1-9299-4c86-abfa-376294498ba4'),(11508,11508,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:41','2024-05-24 14:53:41','4781605a-defe-4ff1-878f-80e7662ff6dd'),(11509,11509,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:41','2024-05-24 14:53:41','8670923e-587d-46b4-b6e0-615686542ca2'),(11510,11510,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:41','2024-05-24 14:53:41','c3d1a772-d79c-4317-bc8f-db3190cc5656'),(11511,11511,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:41','2024-05-24 14:53:41','98c78db9-3a24-4b5d-9011-e8cb6b4c626a'),(11512,11512,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:41','2024-05-24 14:53:41','92a6c696-565e-436f-95b6-2557d6efd2a0'),(11513,11513,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:43','2024-05-24 14:53:43','4d75a464-a5e4-467f-a13f-44e828a9e3da'),(11514,11514,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:43','2024-05-24 14:53:43','e11f9763-0783-4e82-a851-7af7d3be4e3d'),(11515,11515,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:43','2024-05-24 14:53:43','4dcb1962-8354-4c0b-97d9-51051101deb9'),(11516,11516,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:43','2024-05-24 14:53:43','7fb7a9cd-6c84-4d7f-9069-c1f4af0e6f32'),(11517,11517,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:44','2024-05-24 14:53:44','2cdb3884-eaa0-441c-af4d-2b8f31a178a5'),(11518,11518,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:44','2024-05-24 14:53:44','61728eeb-a9fc-49f2-9c2e-03fabb9710de'),(11519,11519,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:45','2024-05-24 14:53:45','6365d5eb-c635-4a85-abac-bc0c40c0a4ee'),(11520,11520,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:45','2024-05-24 14:53:45','2310d037-b0d7-48c5-99ea-2fd1ceecdb84'),(11521,11521,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:45','2024-05-24 14:53:45','587f9ba4-ba9b-4f99-a9b9-289d7248cd92'),(11522,11522,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:45','2024-05-24 14:53:45','1aaadb0d-c24b-4d8c-848e-55d6b1f7beaa'),(11523,11523,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:46','2024-05-24 14:53:46','d81f48c4-609c-4adf-8851-602d1f2bf2a0'),(11524,11524,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:53:46','2024-05-24 14:53:46','3d2f2c55-8ddb-4a14-8c1b-51300e846338'),(11525,11525,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:47','2024-05-24 14:53:47','0ad33814-ff21-46db-b954-906cf15623f8'),(11526,11526,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:47','2024-05-24 14:53:47','636f501e-d06c-47a3-978f-1a1edf395185'),(11527,11527,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:47','2024-05-24 14:53:47','a2c3c89a-3590-49b3-a92f-4601acfa522e'),(11528,11528,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:47','2024-05-24 14:53:47','1f6c5814-9279-438b-b5c0-9b8c4294d311'),(11529,11529,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:49','2024-05-24 14:53:49','2678d0ce-aaaf-4dc8-a2d9-931ef710ff9b'),(11530,11530,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:49','2024-05-24 14:53:49','c80e3f50-7b84-4bee-9655-efb2492afc98'),(11531,11531,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:49','2024-05-24 14:53:49','e7327200-a015-4f99-9dd0-a52931a16003'),(11532,11532,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:49','2024-05-24 14:53:49','a71e5141-6abe-4267-b061-fae47361fa72'),(11533,11533,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:50','2024-05-24 14:53:50','4c55dfad-d4a9-4605-bb0e-0e0283b4484a'),(11534,11534,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:50','2024-05-24 14:53:50','696ef37c-0332-4d01-aff8-3a84668dc2d1'),(11535,11535,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:50','2024-05-24 14:53:50','6452bf84-392b-496a-9ffa-5ee19a9f69a5'),(11536,11536,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:50','2024-05-24 14:53:50','10fc79c2-f2da-4145-9f32-3b063fa5e46f'),(11537,11537,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:51','2024-05-24 14:53:51','93608624-0e51-4a3e-8862-967cdb51feaf'),(11538,11538,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:53:51','2024-05-24 14:53:51','d8550858-62c2-4570-99af-c422f8be6806'),(11539,11539,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:52','2024-05-24 14:53:52','644350b0-5ea6-407f-ba0d-5d3af57a7dbb'),(11540,11540,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:52','2024-05-24 14:53:52','71722cb4-d0ef-415c-ba6f-b281a32f53e3'),(11541,11541,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:52','2024-05-24 14:53:52','8a63d56a-38f1-4448-aa48-3456a42ad53e'),(11542,11542,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:52','2024-05-24 14:53:52','e1342c03-0ca0-4d5d-9b8d-446210a1a483'),(11543,11543,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:53','2024-05-24 14:53:53','352ca1b1-803f-47ee-a5b5-f72a8a9ba3aa'),(11544,11544,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:53','2024-05-24 14:53:53','f04de6d7-aecc-44a0-bd78-bd6369b48713'),(11545,11545,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:53','2024-05-24 14:53:53','84ca1f6d-0a15-4dba-a9dc-a53e59040377'),(11546,11546,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:53','2024-05-24 14:53:53','8cf7dd17-f682-4107-a974-c02ff2b8e080'),(11547,11547,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:54','2024-05-24 14:53:54','81797514-d6c8-4aba-8d61-b4d1b34f14b0'),(11548,11548,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:53:54','2024-05-24 14:53:54','589d50b5-02af-427a-aa48-d983fd5dff22'),(11549,11549,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:55','2024-05-24 14:53:55','c90f1ee7-1089-4a1f-b23e-527806f6cd5e'),(11550,11550,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:55','2024-05-24 14:53:55','3a94d32b-ea81-4d5b-80ae-10db08f0b154'),(11551,11551,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:55','2024-05-24 14:53:55','600a9513-3b5b-4e8b-afaa-79184df37de0'),(11552,11552,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:55','2024-05-24 14:53:55','03bde1b9-819e-4684-82f1-3c226019572a'),(11553,11553,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:56','2024-05-24 14:53:56','0f15c9ec-7633-4cc7-9290-fd627579ec2e'),(11554,11554,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:56','2024-05-24 14:53:56','3f992a61-b246-459f-9146-7d81942130b8'),(11555,11555,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:56','2024-05-24 14:53:56','09e313fc-4736-4e20-8f8e-a3793bdf49aa'),(11556,11556,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:56','2024-05-24 14:53:56','2b8c5cb4-69b1-4ba4-a8ab-b74693abce3c'),(11557,11557,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:57','2024-05-24 14:53:57','66456621-b8b7-493a-b9c2-b1436f90227c'),(11558,11558,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:57','2024-05-24 14:53:57','47fe999b-387f-491b-9a3a-68abeb3e9ee6'),(11559,11559,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:57','2024-05-24 14:53:57','d371fd32-5211-4410-808b-e010623e8517'),(11560,11560,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:57','2024-05-24 14:53:57','c95303db-5557-4bae-a295-837c1c155a50'),(11561,11561,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:58','2024-05-24 14:53:58','f1e8004a-c8e6-4da3-afc4-a16e803b31f4'),(11562,11562,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:58','2024-05-24 14:53:58','2ceddd65-27c6-4ce5-b540-ba3c062bdca1'),(11563,11563,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:58','2024-05-24 14:53:58','c306a73b-1c28-4e2b-aa23-d0414d428638'),(11564,11564,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:58','2024-05-24 14:53:58','d5a086b1-656d-415f-88c6-0a6b5c18db6d'),(11565,11565,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:59','2024-05-24 14:53:59','544afa8d-bf2d-41ad-832d-e937fe6ec4ff'),(11566,11566,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:53:59','2024-05-24 14:53:59','8b3dc694-8522-4334-bb66-64e8bf8c0b02'),(11567,11567,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:59','2024-05-24 14:53:59','3ebfd12f-d0a4-4290-934e-79b00eeee7dc'),(11568,11568,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:53:59','2024-05-24 14:53:59','5bfd144f-f976-4c90-8515-bd798081e370'),(11569,11569,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:59','2024-05-24 14:53:59','d7a3e543-4d04-4f2b-a2fb-bc0eeadc0792'),(11570,11570,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:53:59','2024-05-24 14:53:59','1d7238e7-88ae-471f-bb48-917fc6e6885b'),(11571,11571,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:53:59','2024-05-24 14:53:59','08f9d244-51ba-4365-a815-7abdca814957'),(11572,11572,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:53:59','2024-05-24 14:53:59','f907fe33-9c4a-4de7-a05c-ec5ad7646976'),(11573,11573,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:01','2024-05-24 14:54:01','8ac19cc4-561e-4404-83d0-d385c2d3cdc9'),(11574,11574,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:01','2024-05-24 14:54:01','15cf8733-1395-43bf-bdbe-9d5c5e4a81ed'),(11575,11575,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:01','2024-05-24 14:54:01','c466d74b-020a-410c-98e0-d781160e0c61'),(11576,11576,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:54:01','2024-05-24 14:54:01','50fb1503-6982-49d3-9eb4-80439cf8180b'),(11577,11577,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:02','2024-05-24 14:54:02','48fc1c3f-d308-4cd8-bcdb-6f3d16d3473b'),(11578,11578,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:02','2024-05-24 14:54:02','e16de8ce-42b6-490e-8dfa-d8af8cd69f08'),(11579,11579,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:02','2024-05-24 14:54:02','a8da40ba-e1ab-4910-8ae1-42bf6b82bcb0'),(11580,11580,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:02','2024-05-24 14:54:02','c3e762dc-c0b1-4d06-b0f9-9f4b48bbfeb3'),(11581,11581,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:04','2024-05-24 14:54:04','3ddf2b38-6363-487f-aa3f-3281b9ef83b9'),(11582,11582,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:04','2024-05-24 14:54:04','ccfd2de6-127e-47ba-a943-12a3d6188135'),(11583,11583,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:04','2024-05-24 14:54:04','722ff429-788c-4cd6-91f3-a7d28e1476e0'),(11584,11584,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:04','2024-05-24 14:54:04','9dee2a16-e6db-4781-bce1-ff89301996e2'),(11585,11585,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:05','2024-05-24 14:54:05','15acabad-2466-4a0a-8a0a-00bbe723020f'),(11586,11586,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:05','2024-05-24 14:54:05','96ac7a74-4090-4e60-a987-4165e9225cec'),(11587,11587,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:05','2024-05-24 14:54:05','b43a79f4-6bfc-4547-af06-f635a9cd2b26'),(11588,11588,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:05','2024-05-24 14:54:05','d640ebcb-f086-4f2a-b52f-3e69ffa4666f'),(11589,11589,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:06','2024-05-24 14:54:06','38c95b67-6fcd-4fe8-a592-3ef3138a69c9'),(11590,11590,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:06','2024-05-24 14:54:06','fab717d6-f1af-4ddf-a5ff-7e37b92f667e'),(11591,11591,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:06','2024-05-24 14:54:06','16ef2b5e-80eb-4771-aa4c-f3c06892f17c'),(11592,11592,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:06','2024-05-24 14:54:06','6fa39542-968b-4ead-a4d8-1467b35a0951'),(11593,11593,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:07','2024-05-24 14:54:07','3293ca17-0d0c-47ce-b08f-c66700db34cf'),(11594,11594,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:07','2024-05-24 14:54:07','9230fddd-2725-4dc9-8392-b740999c2755'),(11595,11595,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:07','2024-05-24 14:54:07','3a2262b9-2200-4adf-8b74-2a9f3acf6aae'),(11596,11596,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:07','2024-05-24 14:54:07','7f327572-9b05-4a19-b2e8-d6b6de801f2b'),(11597,11597,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:08','2024-05-24 14:54:08','7d161231-678c-4d02-aeea-997c20081958'),(11598,11598,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:08','2024-05-24 14:54:08','94714dfc-4be8-4596-8c22-1b9e8534a28a'),(11599,11599,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:08','2024-05-24 14:54:08','c25a17df-3bc9-497b-b558-8d9ee9f8153d'),(11600,11600,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:08','2024-05-24 14:54:08','3dc10813-972f-4732-b369-b6d5f2566d74'),(11601,11601,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:09','2024-05-24 14:54:09','37ea8797-d978-4846-b3db-bbf153de8089'),(11602,11602,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:09','2024-05-24 14:54:09','8d99e50e-f2d1-4a58-947e-4236f3cda9a9'),(11603,11603,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:09','2024-05-24 14:54:09','b99e3229-3661-47f3-be34-59bb8a3164c6'),(11604,11604,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:09','2024-05-24 14:54:09','757446d9-8ea4-4c66-ad19-506b03c88e11'),(11605,11605,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:09','2024-05-24 14:54:09','60482df1-bb22-4df7-a5e3-59b7852a446c'),(11606,11606,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:09','2024-05-24 14:54:09','9a8d04be-0046-43d3-9c68-a930807c88da'),(11607,11607,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:09','2024-05-24 14:54:09','d065cba9-d7d5-49de-a434-cbe79b8e07f6'),(11608,11608,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\"}',1,'2024-05-24 14:54:09','2024-05-24 14:54:09','942ece55-6a87-42c7-bf96-755d28dabe4e'),(11609,11609,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:11','2024-05-24 14:54:11','cbbeae67-3b4e-4342-9936-689e8770d01e'),(11610,11610,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:11','2024-05-24 14:54:11','d38ca748-e75c-4500-96d4-196579185f8b'),(11611,11611,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:11','2024-05-24 14:54:11','a6ad44bf-5dc9-4a5d-b922-f101717750ed'),(11612,11612,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:11','2024-05-24 14:54:11','f9395484-f1bb-4e11-8a15-18577cd867e7'),(11613,11613,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:12','2024-05-24 14:54:12','e288f313-ce87-49a7-97af-2cc411f204e7'),(11614,11614,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:12','2024-05-24 14:54:12','d9cd291b-8f91-468d-ace7-d2e0da33bf80'),(11615,11615,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:12','2024-05-24 14:54:12','e4b0a7cc-7e4e-46d7-ae08-a5b8bb61ca2b'),(11616,11616,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:12','2024-05-24 14:54:12','35c84a57-ea7a-44a2-b66b-c6943dca9932'),(11617,11617,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:14','2024-05-24 14:54:14','6a0e437d-a727-4410-a7d4-07411f9aec64'),(11618,11618,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:14','2024-05-24 14:54:14','d1d2bd79-b370-499c-a18c-41646a7813f2'),(11619,11619,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:14','2024-05-24 14:54:14','24405574-9c33-4d3d-a20e-add3e07ce5f0'),(11620,11620,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:14','2024-05-24 14:54:14','7c5969a0-2b53-4bee-a095-12a166d8ba0c'),(11621,11621,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:15','2024-05-24 14:54:15','55d3b55b-d293-4beb-8543-030469f36bb8'),(11622,11622,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:15','2024-05-24 14:54:15','afd4d422-133d-46c1-b592-b65a4f1c8880'),(11623,11623,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:15','2024-05-24 14:54:15','3bba504f-2bd9-44ad-a2ff-a82d48ba75b1'),(11624,11624,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:15','2024-05-24 14:54:15','fa90f410-462c-4bc2-8d04-4354c4276699'),(11625,11625,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:16','2024-05-24 14:54:16','3e04cef6-6610-4b1b-b8f3-481408a602f3'),(11626,11626,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:16','2024-05-24 14:54:16','7bb17ea4-f35b-48cf-9a39-149e98bbd99f'),(11627,11627,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:16','2024-05-24 14:54:16','662e8e7b-369f-468d-a820-4b2a2e38f171'),(11628,11628,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\"}',1,'2024-05-24 14:54:16','2024-05-24 14:54:16','4bfb2441-c892-4177-9f2e-8b3f19ab02a8'),(11629,11629,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:17','2024-05-24 14:54:17','fdfa0f12-f28f-45cc-9eb6-a6f7702041bf'),(11630,11630,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:17','2024-05-24 14:54:17','a5943af6-ede3-4432-8e23-dea3b2ba6d36'),(11631,11631,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:17','2024-05-24 14:54:17','1178d5ef-0bc7-41f5-8d68-17f4ecd771b4'),(11632,11632,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:17','2024-05-24 14:54:17','6ba2c48f-2e52-44e1-a58e-9b9b69467535'),(11633,11633,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:18','2024-05-24 14:54:18','18d6933d-bd2b-4919-adee-e8ce4fbcb3b8'),(11634,11634,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:18','2024-05-24 14:54:18','badb7c7e-bd26-4af8-b2ec-6fe7f5cbfb7c'),(11635,11635,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:18','2024-05-24 14:54:18','a7eeb9dd-efe2-4613-a34f-45b7a8eacc5f'),(11636,11636,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\"}',1,'2024-05-24 14:54:18','2024-05-24 14:54:18','8dc11609-d855-4468-95fc-7b8515d74f55'),(11637,11637,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:19','2024-05-24 14:54:19','1cc3cd76-1361-41c7-aa1a-14d55b4eab4a'),(11638,11638,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:19','2024-05-24 14:54:19','dba26b0e-1ec1-47bf-b521-71fc3b34654b'),(11639,11639,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:19','2024-05-24 14:54:19','d9a3a200-43a5-4109-9910-0ba7fb4eeed8'),(11640,11640,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:19','2024-05-24 14:54:19','95cfc2f9-d486-4b99-a3aa-e4b6dbc0af70'),(11641,11641,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:20','2024-05-24 14:54:20','89ab20cc-7851-4d32-ade6-68a24b03340b'),(11642,11642,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:20','2024-05-24 14:54:20','0a242353-d8a2-46d6-b985-6235385b1883'),(11643,11643,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:20','2024-05-24 14:54:20','2f704bbc-eb4d-4911-ac7a-baae8569ae72'),(11644,11644,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:20','2024-05-24 14:54:20','30664c6a-615e-4e6d-aeb6-fe033b9f5c4b'),(11645,11645,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:21','2024-05-24 14:54:21','409d67f2-6270-42a3-b8a3-963675cdcc4f'),(11646,11646,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:21','2024-05-24 14:54:21','aef078bd-7404-478c-98a5-30ff0148b36b'),(11647,11647,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:21','2024-05-24 14:54:21','2b410ae6-ac0e-4138-b36a-115d7c2b9d06'),(11648,11648,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:21','2024-05-24 14:54:21','02e0f0ae-a913-4d16-8301-86d98817d5fd'),(11649,11649,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:22','2024-05-24 14:54:22','5421f778-d440-4fde-8a0a-88b837e4d158'),(11650,11650,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:22','2024-05-24 14:54:22','37a91477-941b-4d2c-9afc-c6887554dda9'),(11651,11651,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:22','2024-05-24 14:54:22','b4ae2aaa-b310-4db4-b5cb-bc90da499612'),(11652,11652,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:22','2024-05-24 14:54:22','c8c65f1b-02fd-4234-8bbe-c6955949a08c'),(11653,11653,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:23','2024-05-24 14:54:23','b212819b-d93e-4749-b9c0-1b99175ecc95'),(11654,11654,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:23','2024-05-24 14:54:23','721d15a4-8381-4760-b343-521da0986ce0'),(11655,11655,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:23','2024-05-24 14:54:23','37b19720-6627-4084-ad17-86cc2602c2f7'),(11656,11656,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:23','2024-05-24 14:54:23','a925e42e-e026-4ec2-a9c5-759296fb1b97'),(11657,11657,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:24','2024-05-24 14:54:24','8196bdc3-e636-42eb-a027-324c60a3427d'),(11658,11658,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:24','2024-05-24 14:54:24','70aa3425-9931-455f-86d7-b1ea1455a917'),(11659,11659,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:24','2024-05-24 14:54:24','76526980-5980-4c9f-8112-d0d958567610'),(11660,11660,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:54:24','2024-05-24 14:54:24','40b71a6a-eef1-4215-adf9-7906b67a2e47'),(11661,11661,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:25','2024-05-24 14:54:25','7d8149bb-b395-4e27-8b77-6ef1c54b4683'),(11662,11662,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:25','2024-05-24 14:54:25','db48c4ae-016d-4677-a419-73c514339232'),(11663,11663,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:25','2024-05-24 14:54:25','afd83de9-e13f-4f92-b884-4d9c73e4f678'),(11664,11664,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:25','2024-05-24 14:54:25','f37729c0-35a5-4f64-a8c4-aded69ab7288'),(11665,11665,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:26','2024-05-24 14:54:26','394d4e42-287b-42d1-b74e-4a422328a4af'),(11666,11666,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:26','2024-05-24 14:54:26','fdf49e54-87fa-49d3-b987-be8286a17c67'),(11667,11667,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:26','2024-05-24 14:54:26','6aa9f7cf-ad28-4a7b-bb45-2a1dd6590982'),(11668,11668,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:26','2024-05-24 14:54:26','3114e422-e830-4a9b-842c-9ff34bccf303'),(11669,11669,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:26','2024-05-24 14:54:26','b11456c4-6a89-4bb9-b954-1789ec34d3ac'),(11670,11670,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:26','2024-05-24 14:54:26','5d7cf979-8f6d-4f94-a7f4-7509c7ba660b'),(11671,11671,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:26','2024-05-24 14:54:26','e1b312c0-94d7-4772-ae0d-2c9595dec072'),(11672,11672,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:54:26','2024-05-24 14:54:26','6980f9b7-fcb2-4fed-b736-15579e5e432a'),(11673,11673,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:28','2024-05-24 14:54:28','6ced96e5-6e3d-4bcb-9e06-4ae1b31e5584'),(11674,11674,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:28','2024-05-24 14:54:28','d3ac78dd-a4a9-4b8c-a207-6ea63b9b9495'),(11675,11675,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:28','2024-05-24 14:54:28','87451394-6ebd-4eee-9376-5915f41d0e47'),(11676,11676,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:28','2024-05-24 14:54:28','32ffc7cf-934a-46be-8f0e-ab5687692e26'),(11677,11677,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:28','2024-05-24 14:54:28','30718d60-6b29-4a69-8922-d503995531c5'),(11678,11678,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:28','2024-05-24 14:54:28','547fb98f-a3da-48fe-ac9d-08e557041b76'),(11679,11679,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:28','2024-05-24 14:54:28','a8757504-f9b3-485b-8c64-b51de4a01004'),(11680,11680,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health;\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:54:28','2024-05-24 14:54:28','1744c5e9-d455-4ca5-836d-3dcc5edf3426'),(11681,11681,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:29','2024-05-24 14:54:29','97cdb441-04de-4eeb-8360-e673285a601e'),(11682,11682,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:29','2024-05-24 14:54:29','0564544a-b68d-475a-b76e-706cde990acf'),(11683,11683,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:29','2024-05-24 14:54:29','c4181e97-ace0-4ee9-a1eb-d72e0cc6f302'),(11684,11684,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:29','2024-05-24 14:54:29','a9e19f91-9f76-422f-b477-45c21154979e'),(11685,11685,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:29','2024-05-24 14:54:29','26832fdf-0742-4797-aa50-2e885ef301bc'),(11686,11686,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:29','2024-05-24 14:54:29','6a76f7c8-d136-4ced-a04f-9f505d3e38e6'),(11687,11687,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:29','2024-05-24 14:54:29','5fddb68c-2bf8-47bf-b730-95db42590767'),(11688,11688,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health;\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:54:29','2024-05-24 14:54:29','d8c5f72d-fd1a-49d4-9adc-8612938850df'),(11689,11689,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:30','2024-05-24 14:54:30','fb5996f2-b433-4365-bd31-c0a7c05a4380'),(11690,11690,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:30','2024-05-24 14:54:30','29defeeb-bff1-42b5-aa66-ac37029e9b79'),(11691,11691,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:30','2024-05-24 14:54:30','f0babd47-d822-4c41-93a1-f486eb9b34a1'),(11692,11692,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:30','2024-05-24 14:54:30','0511305a-08cd-4762-babb-f98216c964da'),(11693,11693,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:30','2024-05-24 14:54:30','a81d7ebe-ed0f-465c-be41-7453019e50cf'),(11694,11694,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:30','2024-05-24 14:54:30','b601d492-1452-4709-9a7d-78ed817c7489'),(11695,11695,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:30','2024-05-24 14:54:30','755e1d68-41ee-415e-9554-79325444f47c'),(11696,11696,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthc\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:54:31','2024-05-24 14:54:31','b4ae01f2-2115-4e4d-805f-cfeec1a89b45'),(11697,11697,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:32','2024-05-24 14:54:32','d691f248-216e-4dc6-9dbc-f132e696e3e9'),(11698,11698,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:32','2024-05-24 14:54:32','bce1dd35-f2d9-4d22-882f-41a7923425ff'),(11699,11699,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:32','2024-05-24 14:54:32','c56a7b67-3f74-4967-8faa-e19dbb5ee07e'),(11700,11700,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:32','2024-05-24 14:54:32','d657bc66-a1bb-49a1-a2f9-63dfc83e04d5'),(11701,11701,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:32','2024-05-24 14:54:32','2d97a60e-2cf4-45c4-94e6-f1ee642ebd6c'),(11702,11702,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:32','2024-05-24 14:54:32','1eb85cbf-a89e-4d57-b917-64e8baa3bedd'),(11703,11703,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:32','2024-05-24 14:54:32','7f13a2b6-a1d7-42c0-9c06-34e61d0baecc'),(11704,11704,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:54:32','2024-05-24 14:54:32','1c4dbecb-0fa1-43d9-9962-34d227e32ee5'),(11705,11705,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:33','2024-05-24 14:54:33','b04f5436-3f03-49f8-983b-ae11f2007309'),(11706,11706,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:33','2024-05-24 14:54:33','0bed03d3-4b50-4462-9135-cfc50ba06d07'),(11707,11707,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:33','2024-05-24 14:54:33','d00bef11-6471-44d8-bff6-b4d308ef12b0'),(11708,11708,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:33','2024-05-24 14:54:33','9f353559-8291-4dff-bee9-8ec7e23f433f'),(11709,11709,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:34','2024-05-24 14:54:34','07b0e117-1431-4a22-9ae8-c48b581b8b2b'),(11710,11710,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:34','2024-05-24 14:54:34','4bf7c8e9-4033-4f4d-a866-1efc343373cb'),(11711,11711,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:34','2024-05-24 14:54:34','4fbfd79b-1968-44ad-9604-b9455ef61071'),(11712,11712,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:34','2024-05-24 14:54:34','bc7d4741-1425-4cdd-90ec-815f31859997'),(11713,11713,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:35','2024-05-24 14:54:35','9e76415b-058e-4119-bdb3-d56377460a02'),(11714,11714,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:35','2024-05-24 14:54:35','a0dc622e-16e2-4085-b979-b38c1a0534a6'),(11715,11715,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:35','2024-05-24 14:54:35','de5fa3ca-c9a6-48b0-9fbb-cb649333f4af'),(11716,11716,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Per\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:54:35','2024-05-24 14:54:35','c5c63219-aeb2-4f14-83fa-b3d1270ddc44'),(11717,11717,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:36','2024-05-24 14:54:36','467cd5a2-65ff-43a0-9069-4dfbca2f4a4b'),(11718,11718,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:36','2024-05-24 14:54:36','3a2cfedb-0475-4614-85a2-a89dee459c9a'),(11719,11719,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:36','2024-05-24 14:54:36','4cbdc9be-ce76-44d0-8b36-445a761c4ef9'),(11720,11720,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:36','2024-05-24 14:54:36','51f80bec-4b35-4302-8c83-d37ee32318e5'),(11721,11721,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:36','2024-05-24 14:54:36','0f5976fd-1c1b-4789-9389-cafa46f80397'),(11722,11722,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:36','2024-05-24 14:54:36','5d3ff2f2-56a2-44a1-a606-8abfcd8e8efe'),(11723,11723,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:36','2024-05-24 14:54:36','137f3109-db4f-41ba-93d0-ff6eedfb1d11'),(11724,11724,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:54:36','2024-05-24 14:54:36','0c757ca7-bd44-4309-92eb-cd417cad319e'),(11725,11725,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:38','2024-05-24 14:54:38','534a688b-bc28-4320-86b2-5af5e90984af'),(11726,11726,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:38','2024-05-24 14:54:38','40a7d9c6-531b-49d6-8966-f8af5551dba6'),(11727,11727,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:38','2024-05-24 14:54:38','a1cb3543-f5b0-4dc1-87b3-bebf580d8bd5'),(11728,11728,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:38','2024-05-24 14:54:38','d650736f-4521-4c5e-b31e-a9650abe9d9e'),(11729,11729,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:39','2024-05-24 14:54:39','30c80a1c-3fbd-4159-b408-fbd1a64c1ce5'),(11730,11730,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:39','2024-05-24 14:54:39','019acc5e-f874-46b9-8fb7-5c6bfd34516f'),(11731,11731,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:39','2024-05-24 14:54:39','bad19b68-619b-472d-89a5-06a0701ac840'),(11732,11732,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:39','2024-05-24 14:54:39','384eb916-aef6-4daf-811b-101ffe32bb6f'),(11733,11733,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:39','2024-05-24 14:54:39','efa55e8d-9188-49e6-b59c-c2395b49ebaa'),(11734,11734,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:39','2024-05-24 14:54:39','0aec9f9e-a51a-49c3-b7da-97441c6eb913'),(11735,11735,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:39','2024-05-24 14:54:39','61397a79-1960-4b16-acef-62cccaf4b00d'),(11736,11736,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:54:39','2024-05-24 14:54:39','7f18e403-aa7e-41bf-9c0a-a16902f0cd59'),(11737,11737,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:40','2024-05-24 14:54:40','7dba5945-fc2a-4def-aef9-b9582fb1a224'),(11738,11738,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:40','2024-05-24 14:54:40','12085cea-994d-4974-a521-8ef4e2ba5619'),(11739,11739,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:40','2024-05-24 14:54:40','3034af80-56c0-4a2e-9a22-372f09cf603d'),(11740,11740,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:40','2024-05-24 14:54:40','6ef25ad9-13cb-49cc-b736-33e2d681a7e9'),(11741,11741,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:41','2024-05-24 14:54:41','9d0d2062-536b-4498-8d73-29322abc9c00'),(11742,11742,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:41','2024-05-24 14:54:41','89e775b7-7cac-4de7-ae55-c2be5c432064'),(11743,11743,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:41','2024-05-24 14:54:41','894af6eb-c96a-4fd0-807c-89c9043f318d'),(11744,11744,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:41','2024-05-24 14:54:41','7d57c549-757b-4f78-9399-8f3b24b33768'),(11745,11745,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:43','2024-05-24 14:54:43','4bcc7241-4e22-4c19-aac2-3daca3bb08a2'),(11746,11746,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:43','2024-05-24 14:54:43','9f33ac4b-1f2e-44c5-a0a9-1e3c137dcbb4'),(11747,11747,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:43','2024-05-24 14:54:43','6dd5f62f-39ca-4570-b73d-705b19c01132'),(11748,11748,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:43','2024-05-24 14:54:43','dc801106-90b9-436b-a3ea-7c68af872566'),(11749,11749,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:44','2024-05-24 14:54:44','425d6b82-b406-4766-a3bc-e29e8150f1ad'),(11750,11750,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:44','2024-05-24 14:54:44','45968277-2479-4c0d-b043-83e4861b72f5'),(11751,11751,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:44','2024-05-24 14:54:44','c07b4a2d-1965-4220-8e29-735fb55fa9a4'),(11752,11752,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:44','2024-05-24 14:54:44','82dd9e02-a99a-4507-82df-73baa723d22b'),(11753,11753,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:45','2024-05-24 14:54:45','a3dd9756-5b1b-4c20-a337-1cd7cb93393f'),(11754,11754,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:45','2024-05-24 14:54:45','3b27eba5-60ed-40c9-84f3-0f9447dc6663'),(11755,11755,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:45','2024-05-24 14:54:45','728bf0b7-7a2b-4f6a-9a0d-91759ef6cbc3'),(11756,11756,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:45','2024-05-24 14:54:45','49cfe0ee-db5c-4661-9300-e3bcc6b7becd'),(11757,11757,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:46','2024-05-24 14:54:46','40ff899e-b98a-4c9f-8244-ab6495632313'),(11758,11758,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:46','2024-05-24 14:54:46','a50223bf-8216-4ebd-a77e-a55fa5148e9c'),(11759,11759,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:46','2024-05-24 14:54:46','912e7fe5-f165-4ec6-888b-b8777baee991'),(11760,11760,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:46','2024-05-24 14:54:46','9e3cae11-69c4-4ab4-9777-cede6aeb4d9a'),(11761,11761,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:47','2024-05-24 14:54:47','0c321900-5930-4720-9b25-f064cfe5d2ff'),(11762,11762,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:47','2024-05-24 14:54:47','cfbbeead-1282-4704-8f28-8e53d223bd16'),(11763,11763,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:47','2024-05-24 14:54:47','2fde8d9a-8971-47aa-9b30-fd5337ab6ad7'),(11764,11764,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:47','2024-05-24 14:54:47','2f093b7d-048b-499d-bfe7-0d9cb41abe44'),(11765,11765,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:48','2024-05-24 14:54:48','68de546f-63a8-4155-877e-950c2534007f'),(11766,11766,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:48','2024-05-24 14:54:48','c52f0122-cc6e-4221-9a4f-a7ed1b0f0d48'),(11767,11767,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:48','2024-05-24 14:54:48','ee042d4d-d996-4f5d-ad1e-90ae48d58162'),(11768,11768,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:48','2024-05-24 14:54:48','032dd93f-08cb-4b9c-a68f-4401115eb2ad'),(11769,11769,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:49','2024-05-24 14:54:49','8d5264df-7fa1-4b8b-b752-7e468c03a4d0'),(11770,11770,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:49','2024-05-24 14:54:49','9f04ad03-f2d3-4905-9029-ce72055f362a'),(11771,11771,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:49','2024-05-24 14:54:49','da93813a-0dd0-490e-aa79-8e45e0053cf0'),(11772,11772,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:49','2024-05-24 14:54:49','a20394af-aa42-4c65-9664-a910254fc227'),(11773,11773,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:50','2024-05-24 14:54:50','23a17a78-9c77-468c-a776-56d1bbc67b21'),(11774,11774,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:50','2024-05-24 14:54:50','dccfc93a-55e9-4ba8-a23b-b6d9136a0152'),(11775,11775,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:50','2024-05-24 14:54:50','2661b179-7c60-4322-b7c0-8f3c977e98a1'),(11776,11776,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:50','2024-05-24 14:54:50','caeaf8ce-3c98-4aea-ac01-5bceebc63237'),(11777,11777,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:51','2024-05-24 14:54:51','c521c0bc-7ef5-497a-bbd1-0d407efce7fa'),(11778,11778,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:54:51','2024-05-24 14:54:51','05b0df5b-2796-4e9c-b672-2292e5ef5bfb'),(11779,11779,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:53','2024-05-24 14:54:53','c2dfff52-0903-4860-9773-7f5a95698342'),(11780,11780,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:53','2024-05-24 14:54:53','189240fa-dc69-43de-b0f8-ace42b5a6f4e'),(11781,11781,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:53','2024-05-24 14:54:53','3754970b-b063-418b-9ec3-b69a14363865'),(11782,11782,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:53','2024-05-24 14:54:53','85f2cae6-ceab-4ef2-bc9d-77e76b47e06a'),(11783,11783,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:53','2024-05-24 14:54:53','f22fd6a3-dc3c-49b5-b80d-0e99012b3fdf'),(11784,11784,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:54:53','2024-05-24 14:54:53','560d3a9e-9cd9-4faf-bdc7-222fe893caf6'),(11785,11785,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:55','2024-05-24 14:54:55','c3a1975a-1a38-4c87-9dd0-045efca34145'),(11786,11786,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:55','2024-05-24 14:54:55','3ad9d708-4351-4c4e-a971-1052722cf87d'),(11787,11787,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:55','2024-05-24 14:54:55','8d8f9272-9229-4348-b491-5671207cbab9'),(11788,11788,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:55','2024-05-24 14:54:55','21c56cd0-ba0f-43cc-b59b-9ec4e5f59a4f'),(11789,11789,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:55','2024-05-24 14:54:55','1b3fc19d-f7e0-4859-b11f-6ae0dd7f8630'),(11790,11790,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:54:55','2024-05-24 14:54:55','072ea1b6-d4c3-4a33-8529-cfedaef9788e'),(11791,11791,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:57','2024-05-24 14:54:57','fe32d732-169a-4899-b556-1bc18996dcb3'),(11792,11792,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:57','2024-05-24 14:54:57','b21ea1f0-1d11-41f8-bb10-105328648941'),(11793,11793,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:54:57','2024-05-24 14:54:57','f5b9aebd-cddb-41b2-b2de-f55ee9f5a322'),(11794,11794,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:54:57','2024-05-24 14:54:57','5d58d01f-e23d-46e7-83d6-8e18378822bb'),(11795,11795,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:57','2024-05-24 14:54:57','8a739809-7120-4f54-9b23-8f66dcea1b0b'),(11796,11796,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:54:57','2024-05-24 14:54:57','f085d42e-1d20-453f-b10d-40db872943eb'),(11797,11797,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:59','2024-05-24 14:54:59','2a8973e1-3d92-4088-b6e1-d21a3d4be05b'),(11798,11798,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:54:59','2024-05-24 14:54:59','f74790bd-18f0-48a3-b78e-5a6f6fc27eeb'),(11799,11799,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:54:59','2024-05-24 14:54:59','5fa038c3-278d-4752-b0c9-f579d315b7a4'),(11800,11800,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:54:59','2024-05-24 14:54:59','c328fcf2-0c2c-47b7-b4f8-0b0134260362'),(11801,11801,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:00','2024-05-24 14:55:00','4c456abc-f752-4816-975e-2ff404ea170e'),(11802,11802,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:00','2024-05-24 14:55:00','8c6b8886-24f4-4660-8594-558b9157845c'),(11803,11803,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:02','2024-05-24 14:55:02','2d67a125-2705-40bf-8c59-4c6468fd410f'),(11804,11805,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:02','2024-05-24 14:55:02','a43b577c-7cf1-4a07-97be-21ab39e35db2'),(11805,11804,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:02','2024-05-24 14:55:02','f8c6e74a-cc97-40ec-8ffb-d0788d99d38e'),(11806,11806,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:03','2024-05-24 14:55:03','57967a17-8ee9-433c-9bd1-02b67c384c79'),(11807,11807,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:03','2024-05-24 14:55:03','11b55ef1-a9fb-4318-b8ea-8f82c9e247bc'),(11808,11808,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:03','2024-05-24 14:55:03','cd85db59-4ded-4a0f-901f-234b7dac083f'),(11809,11809,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:03','2024-05-24 14:55:03','f1d10021-3c45-49ee-a0f7-948818e5bc0b'),(11810,11810,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:55:03','2024-05-24 14:55:03','c966f941-332f-4b55-94bf-cb45b3d60b6b'),(11811,11811,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:03','2024-05-24 14:55:03','aa2d12a6-09c7-4ebf-8a50-149b939e2cb6'),(11812,11812,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\"}',1,'2024-05-24 14:55:03','2024-05-24 14:55:03','574b57aa-f59b-408b-ae8a-99270f15d1cd'),(11813,11813,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:05','2024-05-24 14:55:05','d06f82db-275a-4bf8-a22c-d45f12970ef7'),(11814,11814,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:05','2024-05-24 14:55:05','eab0171e-bfa4-4bdd-aabf-07d1fa4bc93f'),(11815,11815,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:05','2024-05-24 14:55:05','2dd2c5da-89f2-478f-afed-4a954d3ac9e1'),(11816,11816,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:55:05','2024-05-24 14:55:05','3ce8556e-1d16-48db-9217-e9a9e0feeaae'),(11817,11817,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:05','2024-05-24 14:55:05','db1de7ab-589e-4905-9abf-1bb053a57960'),(11818,11818,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:55:05','2024-05-24 14:55:05','235c245c-b483-443e-9ff1-dd6f7c15c4b1'),(11819,11819,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:06','2024-05-24 14:55:06','8b81d011-5dd4-4a8b-ad57-4cddde829f86'),(11820,11820,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:06','2024-05-24 14:55:06','82a53182-a30a-4e3a-be6b-d0bf3a618d39'),(11821,11821,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:07','2024-05-24 14:55:07','6f6c9389-f9d0-4353-a43a-00128a1b49cd'),(11822,11822,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:07','2024-05-24 14:55:07','a3855801-0343-414b-82a1-7f2b53d6b65e'),(11823,11823,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:08','2024-05-24 14:55:08','450d3644-304b-4077-aedc-ef6cedbde79d'),(11824,11824,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:08','2024-05-24 14:55:08','aeffee89-d09b-486b-9107-eddb22c7bded'),(11825,11825,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:09','2024-05-24 14:55:09','d60bfc7a-f8b6-4355-b335-b16035845a47'),(11826,11826,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:09','2024-05-24 14:55:09','92bac0a3-03eb-4e51-aefb-6d5df466a4d0'),(11827,11827,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:09','2024-05-24 14:55:09','46b580ce-946e-4b31-af7b-1597f16fae8f'),(11828,11828,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:55:09','2024-05-24 14:55:09','be16243a-b496-4056-9884-e2b7cffebe8d'),(11829,11829,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:09','2024-05-24 14:55:09','40f3fb9b-f2ae-4e1c-9b1a-4b99ec39ef73'),(11830,11830,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:55:09','2024-05-24 14:55:09','09510d17-2785-4640-b522-37b63286b3b8'),(11831,11831,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:10','2024-05-24 14:55:10','17579ee6-064a-49e7-98c8-3a84c935092a'),(11832,11832,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:10','2024-05-24 14:55:10','ee19c768-1df2-4d37-8df7-397f1fbad141'),(11833,11833,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:10','2024-05-24 14:55:10','b45f2689-60a2-48d9-9fee-0a565e4035b4'),(11834,11834,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:10','2024-05-24 14:55:10','dcda7592-2dea-442e-b560-e5276031d2e8'),(11835,11835,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:11','2024-05-24 14:55:11','028818e3-9d38-42c4-b22b-1df3d937aa37'),(11836,11836,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:11','2024-05-24 14:55:11','3469e839-ab79-44ef-8cf7-9a9ca3a02e42'),(11837,11837,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:12','2024-05-24 14:55:12','18c6cc18-1b73-4ec0-b812-d420c428a270'),(11838,11838,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:12','2024-05-24 14:55:12','fde224b7-04df-411a-9798-9b5cd72dfd62'),(11839,11839,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:13','2024-05-24 14:55:13','fa06b5b3-8aaa-4acd-b31b-c1d30ea729c8'),(11840,11840,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:13','2024-05-24 14:55:13','15c59042-f165-4bad-8925-ee3c7f1a3a0a'),(11841,11841,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:13','2024-05-24 14:55:13','77500593-3fda-482d-8f68-afbffeba4fb3'),(11842,11842,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:13','2024-05-24 14:55:13','c74a3e86-d690-4aa8-8c01-58114abb6d05'),(11843,11843,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:14','2024-05-24 14:55:14','b006e81b-4b3b-49fe-95dc-2166b1ff967e'),(11844,11844,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:14','2024-05-24 14:55:14','5dda315f-fb55-4dc9-ac13-a9d786b9625e'),(11845,11845,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:14','2024-05-24 14:55:14','57363993-0e61-45e4-b3e9-9b0ba25fce7d'),(11846,11846,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:14','2024-05-24 14:55:14','1c19e50e-a630-4762-a68e-a2a86793e9d1'),(11847,11847,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:15','2024-05-24 14:55:15','a9fc3f12-2b78-4605-bcaa-02750a959178'),(11848,11848,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:15','2024-05-24 14:55:15','b3303424-43bc-4a0a-8f47-49f6cdddd048'),(11849,11849,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:15','2024-05-24 14:55:15','86514808-d5f7-4068-b95a-e11fa09de85c'),(11850,11850,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:15','2024-05-24 14:55:15','24893799-1300-451a-9759-9beca172ebbe'),(11851,11851,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:16','2024-05-24 14:55:16','7cd8c6a3-bb55-44eb-a739-1b2acdde91f1'),(11852,11852,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:16','2024-05-24 14:55:16','f20d4758-1c45-4ed1-b6b6-35f89e1a0857'),(11853,11853,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:16','2024-05-24 14:55:16','42633ee0-8588-4fa3-bcfb-c02ec1583dc3'),(11854,11854,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:16','2024-05-24 14:55:16','c3ddc18f-0cf5-4528-a7e9-0a73f918fa2d'),(11855,11855,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:18','2024-05-24 14:55:18','07f2fff1-29b0-4a47-8691-2eb9ca17ea63'),(11856,11856,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:18','2024-05-24 14:55:18','22f2d9cd-4116-4444-9f6e-c5bb99452d6a'),(11857,11857,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:18','2024-05-24 14:55:18','3883b32c-8542-4526-a5d0-b2c67cfd16ac'),(11858,11858,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:18','2024-05-24 14:55:18','9222c916-0f19-48ed-b45f-3425286293fc'),(11859,11859,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:21','2024-05-24 14:55:21','342550a0-4035-4f5f-9159-c3d98adb4897'),(11860,11860,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:21','2024-05-24 14:55:21','21cd12de-a386-45b3-acd9-d48487a6567c'),(11861,11861,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:21','2024-05-24 14:55:21','4b860101-b627-4556-83ce-d737af783bbd'),(11862,11862,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:22','2024-05-24 14:55:22','ab5324bb-b6fe-4380-9697-7c957e99a9e4'),(11863,11863,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:22','2024-05-24 14:55:22','ba734e4e-dc92-4673-a6cf-9f1e7617f765'),(11864,11864,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:22','2024-05-24 14:55:22','29c499a2-e474-40f2-9a9a-f06817b895ff'),(11865,11865,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:24','2024-05-24 14:55:24','d7224499-fe40-41b1-9cfb-b8fbf9f1ddab'),(11866,11866,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:24','2024-05-24 14:55:24','ec83f5e7-5e5f-4b6c-844f-af5985de0ebc'),(11867,11867,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:24','2024-05-24 14:55:24','57c51e9f-9db2-4077-a2a8-0f64a594b08d'),(11868,11868,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:24','2024-05-24 14:55:24','b1fddc0e-765f-4811-9351-09305da45c3a'),(11869,11869,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:25','2024-05-24 14:55:25','7b000e65-91f7-4345-bd6f-b591cd6433b5'),(11870,11870,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:25','2024-05-24 14:55:25','c8cefaee-6696-4150-90e8-1a9f585bc2b2'),(11871,11871,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:27','2024-05-24 14:55:27','17d9380a-33ab-4ceb-9bac-4f1ba0db1ebb'),(11872,11872,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:27','2024-05-24 14:55:27','eb1d3535-e565-451e-bbaf-1252b76cb6df'),(11873,11873,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:27','2024-05-24 14:55:27','e1855911-4281-4851-ab34-ad4d02c3988f'),(11874,11874,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:27','2024-05-24 14:55:27','8e59a518-41a0-4533-b640-92ea88d52bca'),(11875,11875,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:28','2024-05-24 14:55:28','3bee731a-212c-41dc-9890-a68ed3618bf3'),(11876,11876,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:28','2024-05-24 14:55:28','76071bf0-ad47-449a-92a6-da8d077b9304'),(11877,11877,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:30','2024-05-24 14:55:30','d2e7b4e2-b277-44fa-bbac-ee61cafe5d5c'),(11878,11878,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:30','2024-05-24 14:55:30','983f57a2-a46f-4d3a-814c-040edbae0e60'),(11879,11879,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:30','2024-05-24 14:55:30','7717309a-1075-4604-9492-252198cf4e25'),(11880,11880,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:30','2024-05-24 14:55:30','e37081fc-28ab-4c63-8377-c250263d85b9'),(11881,11881,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:30','2024-05-24 14:55:30','7bbf1706-7f77-4d03-ba0c-d4ddc4418fee'),(11882,11882,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:30','2024-05-24 14:55:30','67092692-6f3f-41d3-88b1-8a6192d29531'),(11883,11883,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:32','2024-05-24 14:55:32','54ddd9d3-350a-40f7-93c5-ed483b6fad50'),(11884,11884,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:32','2024-05-24 14:55:32','18b48279-3047-41ba-8fd6-cf6c22d001cb'),(11885,11885,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:33','2024-05-24 14:55:33','f470c085-eccf-4408-b7ca-a5f2fc2c9444'),(11886,11886,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:33','2024-05-24 14:55:33','7a4ca5cf-5ad8-4a73-830b-72a825adb23c'),(11887,11887,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:33','2024-05-24 14:55:33','f4a8aceb-5323-4801-a22a-827f078b8522'),(11888,11888,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:33','2024-05-24 14:55:33','ae82d22e-9d6f-4e8f-ad04-b8a313d41ecf'),(11889,11889,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:34','2024-05-24 14:55:34','a0b1571f-957b-48d7-8878-56010b758e9d'),(11890,11890,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:34','2024-05-24 14:55:34','503ce994-53f1-487b-83dc-b61b68b72de1'),(11891,11891,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:36','2024-05-24 14:55:36','8b2d4f2e-81a5-4f07-a48f-8184a9257b88'),(11892,11892,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:36','2024-05-24 14:55:36','5e1a4c2d-f5d9-4577-983d-91577019ba94'),(11893,11893,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:36','2024-05-24 14:55:36','4264d74d-da77-413b-b2c3-0bfb93a19025'),(11894,11894,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:36','2024-05-24 14:55:36','42de5ba4-5d10-48fd-912b-40608b6ed00e'),(11895,11895,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:37','2024-05-24 14:55:37','bb6aaef7-2fc2-4bdf-8368-c5b1810d04d1'),(11896,11896,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:37','2024-05-24 14:55:37','db8e3a82-80ed-4bce-acd3-6f294945f5ba'),(11897,11897,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:39','2024-05-24 14:55:39','e4b4c2a6-c2b5-4f09-b3fe-321515446655'),(11898,11898,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:39','2024-05-24 14:55:39','e4bd90e4-b012-475f-8cc8-1008a1e5ed89'),(11899,11899,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:39','2024-05-24 14:55:39','9ce3e786-cef9-40cb-a024-62b5be442a80'),(11900,11900,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:39','2024-05-24 14:55:39','b4a22baf-11ff-4b55-86d5-6fe2396c6bc6'),(11901,11901,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:39','2024-05-24 14:55:39','2f8a794a-6b15-4d03-b98a-e7888649de76'),(11902,11902,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:40','2024-05-24 14:55:40','2c673f2f-5c35-4e51-b878-e9cd07b77bb7'),(11903,11903,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:40','2024-05-24 14:55:40','8e0a5e10-45ed-471c-b9a5-26c8d2331db0'),(11904,11904,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:40','2024-05-24 14:55:40','4e3f0a67-2154-4d9a-a286-0b8e25acc1f3'),(11905,11905,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:41','2024-05-24 14:55:41','d5529fb4-4ebf-4455-843d-41752613e04f'),(11906,11906,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:41','2024-05-24 14:55:41','f02dfd54-f75d-46d5-ad76-a0a29e7f1ea0'),(11907,11907,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:41','2024-05-24 14:55:41','d7501822-0005-447e-b30a-acd0fe8871f9'),(11908,11908,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:41','2024-05-24 14:55:41','2004ee5a-b6d4-48b7-9a56-b5a4539c7123'),(11909,11909,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:42','2024-05-24 14:55:42','c48b69e5-5eff-400b-9128-2f78acde4c34'),(11910,11910,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:42','2024-05-24 14:55:42','2ff2ab02-12a0-4d2a-ad86-edca159d1cde'),(11911,11911,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:42','2024-05-24 14:55:42','37d6d048-ddea-44fa-b22c-24e41bfcac04'),(11912,11912,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:42','2024-05-24 14:55:42','de987915-7dcc-4ea4-a6f8-20d6fa8295c4'),(11913,11913,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:44','2024-05-24 14:55:44','694c6af1-3ebb-442a-9003-9ed5f8a5a5cd'),(11914,11914,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:44','2024-05-24 14:55:44','fe975061-ba2c-4a06-a79e-698f1f92b65f'),(11915,11915,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:45','2024-05-24 14:55:45','466df2a6-43c5-482a-892e-7454af2ba7ae'),(11916,11916,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:45','2024-05-24 14:55:45','83d11349-2910-4d41-a2d6-27fa1e36d610'),(11917,11917,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:45','2024-05-24 14:55:45','679bce7a-f759-411f-8e00-b380ce0a6ffb'),(11918,11918,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:45','2024-05-24 14:55:45','81bd033a-4308-4d94-9e3e-af7bee8ad0c5'),(11919,11919,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:47','2024-05-24 14:55:47','a7375cf0-4e8b-4054-9c34-9d72c898bb63'),(11920,11920,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:47','2024-05-24 14:55:47','76b6dc19-5cbe-470d-8135-fcb8f31af06f'),(11921,11921,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:47','2024-05-24 14:55:47','a0c7e995-27ea-4cd9-81e9-0c5d29d3e0f4'),(11922,11922,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:47','2024-05-24 14:55:47','7f0af3e4-f846-442f-a716-e91290244183'),(11923,11923,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:47','2024-05-24 14:55:47','562fc5d8-d9d3-4bba-ad28-0b5c6d1599d4'),(11924,11924,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:47','2024-05-24 14:55:47','2b30a883-a84b-4c11-ac09-c15a4939bf04'),(11925,11925,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:48','2024-05-24 14:55:48','99c444da-b36b-462e-83ce-1c0a69b1982a'),(11926,11926,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:55:48','2024-05-24 14:55:48','751e9895-58a1-4fb3-afaa-f4e05ef6baf9'),(11927,11927,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:48','2024-05-24 14:55:48','9f631f31-ae0d-4ec1-a7ed-0103eaae4732'),(11928,11928,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:55:48','2024-05-24 14:55:48','7cd2aae4-87f7-4f2c-a9be-524c1619ed05'),(11929,11929,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:48','2024-05-24 14:55:48','c61b05cc-c62c-405e-8eee-861ae447ec5c'),(11930,11930,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:55:48','2024-05-24 14:55:48','16c60d7d-3464-497b-a3ce-52a911ad1fb4'),(11931,11931,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:49','2024-05-24 14:55:49','b202f92a-2866-4b54-89ff-29bbd1a954f4'),(11932,11932,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:49','2024-05-24 14:55:49','1739669b-0efc-4cbf-a51c-03156f4f2038'),(11933,11933,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:50','2024-05-24 14:55:50','545598a6-5ae1-425a-a8c4-f8879f4b7fe1'),(11934,11934,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:50','2024-05-24 14:55:50','3ba4b4c5-228f-47ee-91b2-e8bf28d0341b'),(11935,11935,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:50','2024-05-24 14:55:50','ee81029b-b598-4374-9a16-595967657438'),(11936,11936,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:50','2024-05-24 14:55:50','dc5f8ace-521d-4b16-889a-9ad22cc37e83'),(11937,11937,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:52','2024-05-24 14:55:52','cd9ea89a-bc5d-4588-9189-9497f44fdee9'),(11938,11938,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:52','2024-05-24 14:55:52','b6250f40-e22d-44e6-a870-b9ce97136026'),(11939,11939,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:52','2024-05-24 14:55:52','58b87314-7b28-4b1f-8692-b1be3d912ba7'),(11940,11940,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:55:52','2024-05-24 14:55:52','c81ee7ea-c01f-4781-8e26-20f0d3182f39'),(11941,11941,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:52','2024-05-24 14:55:52','dfd5536e-63fb-41c8-aedd-c2894ade2ac0'),(11942,11942,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:55:52','2024-05-24 14:55:52','50fef0f5-409b-4fa3-8c38-1fc9adea908a'),(11943,11943,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:52','2024-05-24 14:55:52','38a7ec09-ae6e-4079-ae6e-80fe7bc08a57'),(11944,11944,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:55:52','2024-05-24 14:55:52','847f1be6-9a2c-45fe-b1b4-e4aefa007ccd'),(11945,11945,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:54','2024-05-24 14:55:54','fa8cded1-c86c-418f-979e-fc2acdda95aa'),(11946,11946,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:54','2024-05-24 14:55:54','5b96b447-e350-4b4f-838d-dcd20b0abf95'),(11947,11947,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:54','2024-05-24 14:55:54','1653fb9e-179a-42ac-bc61-1d3cbdd6e37c'),(11948,11948,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:54','2024-05-24 14:55:54','f1172c63-1cd6-4e00-b5a1-66659f2fc17d'),(11949,11949,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:54','2024-05-24 14:55:54','fd5a5b91-9895-4fff-b14f-3b99a6c29518'),(11950,11950,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:55','2024-05-24 14:55:55','0dec13eb-eb42-4bed-9b97-8709ca97c710'),(11951,11951,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:56','2024-05-24 14:55:56','3b330f04-0a05-4af6-9d9c-2f3608bf2950'),(11952,11952,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:57','2024-05-24 14:55:57','0e11d450-2ea9-43a2-b270-5538b98f89cf'),(11953,11953,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:57','2024-05-24 14:55:57','9644a0c0-d380-45b5-a044-dbaf06357308'),(11954,11954,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:57','2024-05-24 14:55:57','64c0d738-500a-4a6f-ab46-8d8a0dc42248'),(11955,11955,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:57','2024-05-24 14:55:57','80e6d76a-210d-403a-8e90-91d4eb72c085'),(11956,11956,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:55:57','2024-05-24 14:55:57','49a802d3-3283-4654-9728-1520e9278598'),(11957,11957,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:59','2024-05-24 14:55:59','0b164ab8-df5c-4d17-8c1f-f55c2d4ee4e2'),(11958,11958,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:55:59','2024-05-24 14:55:59','9cbcd43c-efd8-4b95-8f3f-908e40457173'),(11959,11959,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:55:59','2024-05-24 14:55:59','4b53f2a0-1dd8-4fbe-87eb-eb29e2f9b22c'),(11960,11960,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:55:59','2024-05-24 14:55:59','0a5a511f-88b3-41af-b098-a7a311370265'),(11961,11961,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:00','2024-05-24 14:56:00','78e53feb-e029-4e8e-8aa8-154741f26224'),(11962,11962,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:56:00','2024-05-24 14:56:00','8dd0010d-71f5-4b3c-8924-a087992b6e8c'),(11963,11963,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:02','2024-05-24 14:56:02','ccd68674-75a7-4f26-a5e3-e48237dd7997'),(11964,11964,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:02','2024-05-24 14:56:02','36d6ad4d-9b53-428c-9fed-ef553fc8d543'),(11965,11965,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:02','2024-05-24 14:56:02','fe91868b-c9cb-4d3d-9945-eefb97381864'),(11966,11966,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:02','2024-05-24 14:56:02','2b15c3ea-e244-47b9-89f2-79c9e23b94d9'),(11967,11967,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:03','2024-05-24 14:56:03','ed756aa0-c1a2-4ea5-9aca-16030e2e3d52'),(11968,11968,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:56:03','2024-05-24 14:56:03','89b7e0f6-67fb-4be4-b254-b70ebb284a19'),(11969,11969,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:04','2024-05-24 14:56:04','53a4c5d7-2f73-4611-ad6d-30945d864fcc'),(11970,11970,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:04','2024-05-24 14:56:04','008734b4-4b3a-4ca4-b345-c70c491321ad'),(11971,11971,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:04','2024-05-24 14:56:04','d8fad21e-2c3c-47ef-962b-344e88e7379f'),(11972,11972,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:04','2024-05-24 14:56:04','ae0fe484-584c-490c-a979-2db0f2f3dc9c'),(11973,11973,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:05','2024-05-24 14:56:05','9028806c-9e94-4353-a9cd-f2ab1e88d8d9'),(11974,11974,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:56:05','2024-05-24 14:56:05','1d634a1e-ef8e-45b2-a49d-f93f888f6053'),(11975,11975,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:07','2024-05-24 14:56:07','8bfd4293-a602-4829-9c9c-68737dd2aafd'),(11976,11976,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:07','2024-05-24 14:56:07','37cba191-4e81-4ac5-901d-9850cc138e66'),(11977,11977,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:07','2024-05-24 14:56:07','e816aada-a689-46ba-90d1-3367dea227a7'),(11978,11978,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:07','2024-05-24 14:56:07','f6b3390e-76f3-45d0-936d-330ea3d82c1c'),(11979,11979,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:08','2024-05-24 14:56:08','d854a471-d2c5-47a6-a189-0ac54ce2b38b'),(11980,11980,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:56:08','2024-05-24 14:56:08','8a36786b-6acc-47fd-ad45-cd7520169968'),(11981,11981,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:09','2024-05-24 14:56:09','a0d017fe-6599-42ce-bef2-7fba425a6694'),(11982,11982,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:09','2024-05-24 14:56:09','6fece025-3667-4138-8f9b-73147e5bb088'),(11983,11983,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:09','2024-05-24 14:56:09','07932957-c823-4aef-8a1d-1dee298496a0'),(11984,11984,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:09','2024-05-24 14:56:09','dd4c2bba-8b0d-41f1-b6e4-e06d532fd5d9'),(11985,11985,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:10','2024-05-24 14:56:10','0f9a86c4-3e8e-4131-a9bf-83cce3189951'),(11986,11986,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:56:10','2024-05-24 14:56:10','a948686d-37b4-4406-a2bb-d489c0cde5e1'),(11987,11987,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:12','2024-05-24 14:56:12','009847da-9826-4c4b-bcf0-4d4505fd5e81'),(11988,11988,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:12','2024-05-24 14:56:12','843bdc8f-09f1-46c0-8364-2142cb8a867f'),(11989,11989,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:12','2024-05-24 14:56:12','b83bcf10-0df0-4e54-8bb3-f97f243c0ad5'),(11990,11990,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:12','2024-05-24 14:56:12','c6b9a16f-4ffd-42b6-9a1f-2dff66bce0d9'),(11991,11991,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:14','2024-05-24 14:56:14','ca772b1c-d14e-42f5-ae89-30efef706572'),(11992,11992,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:14','2024-05-24 14:56:14','475eee24-26c8-4f34-aff3-dde288191ee5'),(11993,11993,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:14','2024-05-24 14:56:14','41170307-daf9-4f1d-b621-4b8d1897e807'),(11994,11994,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:14','2024-05-24 14:56:14','12a17793-7024-431a-ae00-84bef9fd76d7'),(11995,11995,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:16','2024-05-24 14:56:16','1fffd2f6-f25e-48c3-93a5-2e58e04c6f38'),(11996,11996,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:16','2024-05-24 14:56:16','5b83c0bc-a6a4-4e45-9747-b56ec61c243d'),(11997,11997,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:16','2024-05-24 14:56:16','beb7fb44-3612-4151-aab7-bd50149ab7c9'),(11998,11998,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:16','2024-05-24 14:56:16','7f338193-5ff9-4a66-98e6-6a1f0bc5f702'),(11999,11999,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:18','2024-05-24 14:56:18','a435405c-6abd-4aba-8745-7ed92fdc511f'),(12000,12000,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:18','2024-05-24 14:56:18','81ea00af-b150-4cb1-8bb0-505cb1d24f7b'),(12001,12001,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:18','2024-05-24 14:56:18','06b70220-07d2-415a-9fba-78c043425230'),(12002,12002,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:18','2024-05-24 14:56:18','6443b3fb-5253-42c1-8daa-fd959127105f'),(12003,12003,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:20','2024-05-24 14:56:20','0ea012b4-945c-4b5f-933a-699eb83998b6'),(12004,12004,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:20','2024-05-24 14:56:20','9c53918c-71db-49c6-86a6-6da86547b420'),(12005,12005,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:20','2024-05-24 14:56:20','62747060-e122-46d2-b457-13c261fdebc9'),(12006,12006,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:20','2024-05-24 14:56:20','51a4264e-3ba4-4646-bccd-831184091017'),(12007,12007,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:22','2024-05-24 14:56:22','a70fd3c3-246a-4abb-8e53-ac3891d5665d'),(12008,12008,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:22','2024-05-24 14:56:22','6ae2dfec-e2d8-4bab-8d62-db0d86d304e9'),(12009,12009,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:22','2024-05-24 14:56:22','cc7a5763-67f8-452c-af0e-cb49395b595c'),(12010,12010,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:22','2024-05-24 14:56:22','c6e1f34c-0e56-4c9e-be93-19a0876f5c6a'),(12011,12011,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:24','2024-05-24 14:56:24','3e672258-601a-4d24-a538-5bf48ef80a80'),(12012,12012,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:24','2024-05-24 14:56:24','da0b6dba-d520-4480-b0da-1ebce477d1d4'),(12013,12013,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:24','2024-05-24 14:56:24','54a7c047-2159-4660-b0e4-e1f1ae7697ba'),(12014,12014,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:24','2024-05-24 14:56:24','4d8cbfa1-6947-430f-a9f2-7fe44850a656'),(12015,12015,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:26','2024-05-24 14:56:26','75f61756-3b61-44e2-9e8c-7e9cf9a7b35c'),(12016,12016,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:26','2024-05-24 14:56:26','97a666b5-4bd6-441e-b3f4-c5a66261b1bb'),(12017,12017,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:26','2024-05-24 14:56:26','30107de7-bf41-4d3b-a6fb-f24491327815'),(12018,12018,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:26','2024-05-24 14:56:26','6b5c8a6c-7fa4-47e8-a6da-b1a8f0ba073c'),(12019,12019,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:28','2024-05-24 14:56:28','8e26d8e6-74f1-48b4-9718-c5ff93edd4b0'),(12020,12020,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:56:28','2024-05-24 14:56:28','a8b0bf7a-f1ab-4472-9b96-37376a836cfb'),(12021,12021,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:28','2024-05-24 14:56:28','2a9910ae-b022-42f4-8261-3e04d68c05be'),(12022,12022,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:56:28','2024-05-24 14:56:28','59ac0845-a85e-41c3-b04a-8da99b122b3d'),(12023,12023,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:28','2024-05-24 14:56:28','45fdf4a3-87d1-4440-a298-ca0c3b3581cb'),(12024,12024,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\"}',1,'2024-05-24 14:56:28','2024-05-24 14:56:28','4ef404d3-5a4e-4f54-9988-a0197a00b466'),(12025,12025,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:31','2024-05-24 14:56:31','e4c2b4c0-7d08-47ca-891e-88e99ed8bb44'),(12026,12026,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:31','2024-05-24 14:56:31','9fd72166-7e45-437d-aa96-46c7fe256f07'),(12027,12027,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:31','2024-05-24 14:56:31','83e182e0-d6e9-4010-8930-9cadfa255cf9'),(12028,12028,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:31','2024-05-24 14:56:31','872123e4-7329-4a91-9f19-078a65da0043'),(12029,12029,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:32','2024-05-24 14:56:32','2f284e5e-c770-4766-94b0-cccb12878a9e'),(12030,12030,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:56:32','2024-05-24 14:56:32','28f49b3c-2d56-45d2-a4a1-0daa00285b4b'),(12031,12031,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:32','2024-05-24 14:56:32','04087dce-66b5-4881-b21f-81641a61e5b7'),(12032,12032,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:56:32','2024-05-24 14:56:32','e006fd64-9a25-4876-93d5-77e6dd075cef'),(12033,12033,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:32','2024-05-24 14:56:32','35cbc57b-72eb-43a1-a736-5088867465c6'),(12034,12034,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\"}',1,'2024-05-24 14:56:32','2024-05-24 14:56:32','94519b4a-0068-4a59-a1ad-ce26f991dacd'),(12035,12035,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:34','2024-05-24 14:56:34','4aab3591-33f7-4787-bcf9-d91466dde96b'),(12036,12036,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:34','2024-05-24 14:56:34','22530803-8a2c-430c-9f49-321ff22f063b'),(12037,12037,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:34','2024-05-24 14:56:34','70fd852f-491c-4d74-a4de-eeac70926a7a'),(12038,12038,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:34','2024-05-24 14:56:34','5b8cac86-694c-499d-ab15-f7e719619913'),(12039,12039,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:36','2024-05-24 14:56:36','56240c04-3eec-47e3-811b-d1d5599574e0'),(12040,12040,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:36','2024-05-24 14:56:36','309a7c34-954b-42e3-9d79-7ad53c9073e4'),(12041,12041,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:36','2024-05-24 14:56:36','4ae6bb98-0a9c-4b96-b7f7-618750a93fb4'),(12042,12042,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:37','2024-05-24 14:56:37','49abad02-fa3c-471c-af15-6f5e46676557'),(12043,12043,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:38','2024-05-24 14:56:38','ef9c0400-a0af-4f12-804b-ee2b494b8fe1'),(12044,12044,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:38','2024-05-24 14:56:38','5838535e-62d7-448f-ae2a-ca4f2237e7b3'),(12045,12045,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:38','2024-05-24 14:56:38','dc63a55f-f974-48a2-90c9-e09d86b96a58'),(12046,12046,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:38','2024-05-24 14:56:38','e7df5165-1ee8-46cc-a5cb-d294bf7e0966'),(12047,12047,1,'Chicago Department of Public Health','chicago-department-of-public-health','resource-sources/chicago-department-of-public-health',NULL,1,'2024-05-24 14:56:40','2024-05-24 14:56:52','2d898ba3-bbac-4fce-a787-f1c1f4ba0c5b'),(12048,12048,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:41','2024-05-24 14:56:41','a119881b-1808-4c29-a842-0874d0546903'),(12049,12049,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:41','2024-05-24 14:56:41','6b91694b-d5e3-4b3a-8ba7-879bf5f5e538'),(12050,12050,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:41','2024-05-24 14:56:41','c6b48b38-ccd5-4e89-8670-b70af867e194'),(12051,12051,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:41','2024-05-24 14:56:41','5fad1f05-032e-41de-9d48-68c29e45a3bc'),(12052,12052,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:43','2024-05-24 14:56:43','19089a12-98ad-4528-9c67-b122ab967198'),(12053,12053,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:43','2024-05-24 14:56:43','28c1f135-c1ac-4156-9730-cef7eb5b3239'),(12054,12054,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:43','2024-05-24 14:56:43','93295c94-6f23-4f91-ac24-386730ca03f5'),(12055,12055,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:43','2024-05-24 14:56:43','dbd896b5-f3e1-4556-a84f-ceb10a578969'),(12056,12056,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:44','2024-05-24 14:56:44','5b2204a2-0b66-4f40-b385-f9a23a5ef1e7'),(12057,12057,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:44','2024-05-24 14:56:44','e07ed646-e964-4d53-a1c6-2c133c7e7d42'),(12058,12058,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:45','2024-05-24 14:56:45','2d2e93f9-59b5-4f70-9ed2-ffc34d5996db'),(12059,12059,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:45','2024-05-24 14:56:45','1bea7edd-d445-42ef-acfc-8364c040b696'),(12060,12060,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:46','2024-05-24 14:56:46','9a310bc7-cbf7-400d-a1b1-2cb6f3aa3486'),(12061,12061,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:46','2024-05-24 14:56:46','80ca139a-7a37-4e7e-9ba6-3ea6d8cc3697'),(12062,12062,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:47','2024-05-24 14:56:47','0f302243-8ee2-4cc0-89a6-8ceba5f70ea5'),(12063,12063,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:47','2024-05-24 14:56:47','9aaa51f7-5a98-4ebb-becd-7b346e624242'),(12064,12064,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:48','2024-05-24 14:56:48','32059417-623e-4b77-beb8-a13cce0ad5c6'),(12065,12065,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:48','2024-05-24 14:56:48','e9c6717c-fb13-4a0f-b332-2087b7899210'),(12066,12066,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:49','2024-05-24 14:56:49','d5ec9403-782d-4654-b8f6-468e84e06bab'),(12067,12067,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:49','2024-05-24 14:56:49','a1b64907-effe-43bd-bb90-02e14c1987e3'),(12068,12068,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:51','2024-05-24 14:56:51','55b69c44-3505-47b4-9a26-0c711551ec53'),(12069,12069,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:51','2024-05-24 14:56:51','3cdaecb5-6a89-409f-bcf3-eae308d5a123'),(12070,12070,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:51','2024-05-24 14:56:51','6b76d44c-1b7b-494d-8f5f-9b12f49e1745'),(12071,12071,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:51','2024-05-24 14:56:51','012de6ef-e583-43b8-9b06-689dac89cd30'),(12072,12072,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:54','2024-05-24 14:56:54','4afa669c-5f22-4be7-8cdb-963bff9a4d62'),(12073,12073,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:54','2024-05-24 14:56:54','b626db51-9573-46c4-bd47-f528bb34673e'),(12074,12074,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:55','2024-05-24 14:56:55','75ca7393-ffd8-4375-82d1-1557fd524d26'),(12075,12075,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:55','2024-05-24 14:56:55','f2c21ecf-558f-4cf8-8d71-56cabe858453'),(12076,12076,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:57','2024-05-24 14:56:57','3a28249b-6d8d-4c90-ab7e-5e28ccb76cdb'),(12077,12077,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:57','2024-05-24 14:56:57','acc85bdd-fb25-46fb-83c2-4d17198d3788'),(12078,12078,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:57','2024-05-24 14:56:57','1894aa8f-0dac-4fab-990e-c8aa874bc2f2'),(12079,12079,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:57','2024-05-24 14:56:57','4656f199-2547-4315-bdc3-ac665fbac9b5'),(12080,12080,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:59','2024-05-24 14:56:59','c9e34b41-a0bd-4b18-898c-e6ece171ca7e'),(12081,12081,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:56:59','2024-05-24 14:56:59','51a30376-01f3-45c3-9c56-5197c33bbb44'),(12082,12082,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:56:59','2024-05-24 14:56:59','9626f351-399c-46f3-8aac-64c90fd571e4'),(12083,12083,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:56:59','2024-05-24 14:56:59','228b82d7-e056-41d1-87aa-6f11fa585ffb'),(12084,12084,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:01','2024-05-24 14:57:01','9a1f6c5c-e78a-4c38-9050-8d009acbf656'),(12085,12085,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:01','2024-05-24 14:57:01','6e9b0a74-0386-4c33-9093-4e1ef93e3a41'),(12086,12086,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:01','2024-05-24 14:57:01','5b6542f1-382b-4f22-ba59-3452f54bbc5d'),(12087,12087,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:01','2024-05-24 14:57:01','412f5a96-ef86-45b3-bf72-d40cfc36b607'),(12088,12088,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:03','2024-05-24 14:57:03','783bf279-2fa6-46d5-9643-cef97d6fe043'),(12089,12089,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:03','2024-05-24 14:57:03','053eb8e4-77a0-4e2b-babf-bde9170c6d9b'),(12090,12090,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:03','2024-05-24 14:57:03','719c5669-593b-4fc6-ba20-1c0a0e196e9c'),(12091,12091,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:03','2024-05-24 14:57:03','cd17da21-8507-4b56-b686-a985a77fc895'),(12092,12092,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:05','2024-05-24 14:57:05','448ec732-17dc-4235-a5fb-40e7c3e1af9b'),(12093,12093,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:06','2024-05-24 14:57:06','ced0d160-e747-4e42-80b5-823fb24d700b'),(12094,12094,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:06','2024-05-24 14:57:06','52421ab4-40a9-4756-bcd6-664acd697753'),(12095,12095,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:06','2024-05-24 14:57:06','56cf9a50-fd50-4e0b-9df4-00fff50a5198'),(12096,12096,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:06','2024-05-24 14:57:06','45037d41-b823-4813-b9a2-309809d2afd5'),(12097,12097,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:57:06','2024-05-24 14:57:06','18647425-1648-433f-9e98-fcb875369249'),(12098,12098,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:06','2024-05-24 14:57:06','a969eab1-8d19-41b1-b6f1-6a1facef0906'),(12099,12099,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:57:06','2024-05-24 14:57:06','ff35981d-5c90-4a6d-a61e-a094b5541bfb'),(12100,12100,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:06','2024-05-24 14:57:06','9e837940-0eb5-4310-8215-d1b1d9278bac'),(12101,12101,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\"}',1,'2024-05-24 14:57:06','2024-05-24 14:57:06','65875cec-a0ea-49e1-a90f-e61acb7ebcd2'),(12102,12102,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:08','2024-05-24 14:57:08','157ad3ef-8505-45d9-8f27-ea47345ef724'),(12103,12103,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:08','2024-05-24 14:57:08','f1645e40-3631-4671-80ef-366c1584ad83'),(12104,12104,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:08','2024-05-24 14:57:08','d928499a-80c6-496a-a259-2217367789ee'),(12105,12105,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:08','2024-05-24 14:57:08','9377fabf-47f9-4996-a1d0-e168e6c0ab62'),(12106,12106,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:10','2024-05-24 14:57:10','35ab3ea7-c8ec-48c0-a563-c5420c6bb138'),(12107,12107,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:10','2024-05-24 14:57:10','bde5c9e6-5230-4346-a9a9-de5d00c85722'),(12108,12108,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:10','2024-05-24 14:57:10','9b6249ba-db50-4903-aefc-49a71f6d6abf'),(12109,12109,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:10','2024-05-24 14:57:10','3d023c54-77fa-4556-9f38-b87f654c214e'),(12110,12110,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:10','2024-05-24 14:57:10','622a0478-10e9-47d8-af6d-5be120bf70bf'),(12111,12111,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:57:10','2024-05-24 14:57:10','a812c4bf-0b70-42f5-a64b-953f8bdb8587'),(12112,12112,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:10','2024-05-24 14:57:10','a5c07249-bec2-4cff-b443-83a0081d4c1b'),(12113,12113,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:57:10','2024-05-24 14:57:10','ddd57441-99fa-4123-aed8-b5a4b8927309'),(12114,12114,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:10','2024-05-24 14:57:10','84e2ebb5-a4e2-433e-b4ef-8a8e8e8a59d1'),(12115,12115,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\"}',1,'2024-05-24 14:57:10','2024-05-24 14:57:10','16fc23c4-21f2-4003-935f-df78e8c6f21b'),(12116,12116,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:13','2024-05-24 14:57:13','765b0182-d3ad-4f33-a1e1-0f1cf9e0edbf'),(12117,12117,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:13','2024-05-24 14:57:13','e0628227-7a2b-4d01-a3f9-935ec860065f'),(12118,12118,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:13','2024-05-24 14:57:13','5a7e4f5e-57eb-404d-9c36-8003f4c085e4'),(12119,12119,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:13','2024-05-24 14:57:13','991fcb69-32a6-4aac-a687-256a1cad49d1'),(12120,12120,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:15','2024-05-24 14:57:15','0bcb0786-0048-406c-abca-062eafbf7ab6'),(12121,12121,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:15','2024-05-24 14:57:15','e4ac9b26-b842-4698-bdef-6f21661beb18'),(12122,12122,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:15','2024-05-24 14:57:15','9acb5854-3d2d-4d4c-af5c-2454bf3916b9'),(12123,12123,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:15','2024-05-24 14:57:15','5a9275ff-b8e5-48e5-9ee5-7627f6c4cba5'),(12124,12124,1,'CDC; Chicago Department of Public Health','cdc-chicago-department-of-public-health','resource-sources/cdc-chicago-department-of-public-health',NULL,1,'2024-05-24 14:57:16','2024-05-24 14:57:28','647a3d32-1814-4d6e-a91a-0b1b9c8f550f'),(12125,12125,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:18','2024-05-24 14:57:18','7236c265-02e4-423d-8168-66b53e0b78f3'),(12126,12126,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:18','2024-05-24 14:57:18','7d9db904-36a6-4001-9e78-e0c60f34d44a'),(12127,12127,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:18','2024-05-24 14:57:18','3c994381-1d96-43a7-bee5-751c876fc8d6'),(12128,12128,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:18','2024-05-24 14:57:18','f780f512-14d0-4686-97ea-d1c65bb3e318'),(12129,12129,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:22','2024-05-24 14:57:22','3202c140-b103-464e-8ba3-9a0951681126'),(12130,12130,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:22','2024-05-24 14:57:22','1872e5d2-50b3-4254-91f5-4462ab0317c1'),(12131,12131,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:22','2024-05-24 14:57:22','9dd14a98-9056-4b72-830f-7dca12941dc7'),(12132,12132,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:22','2024-05-24 14:57:22','33a61008-036c-4663-a60c-ac83b2890cdc'),(12133,12133,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:24','2024-05-24 14:57:24','8b26d73b-faa6-4d4c-8798-f13365d166ed'),(12134,12134,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:24','2024-05-24 14:57:24','a0362163-df2a-47f5-bc21-74d366467b5d'),(12135,12135,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:24','2024-05-24 14:57:24','c750d473-e749-411d-8ce3-9e83324f1bc0'),(12136,12136,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:24','2024-05-24 14:57:24','9d55adba-c8a7-4c4e-ad20-ad9784ea5127'),(12137,12137,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:26','2024-05-24 14:57:26','f5301fc3-8bd9-4860-a22b-b8a241a2cb5d'),(12138,12138,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:26','2024-05-24 14:57:26','363329bf-1b5f-4c13-9761-0760167b0854'),(12139,12139,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:26','2024-05-24 14:57:26','3713dcad-e8c3-4f5d-a1e2-cfeb03b53c28'),(12140,12140,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:26','2024-05-24 14:57:26','8c6119a7-a630-4e7b-933d-701396db3e9c'),(12141,12141,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:30','2024-05-24 14:57:30','c34dd436-78e0-4a4c-94d8-053aa0bc2697'),(12142,12142,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:30','2024-05-24 14:57:30','eb0c9d76-260e-44b7-a0be-f7c40721e4f3'),(12143,12143,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:30','2024-05-24 14:57:30','9ab5838c-21a6-4d10-bf8f-a338a6fdc445'),(12144,12144,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:30','2024-05-24 14:57:30','75a8c949-e019-4b86-9ecb-4135df5e4d8d'),(12145,12145,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:32','2024-05-24 14:57:32','acbb589c-c50e-4a35-9fbf-57b259424ba9'),(12146,12146,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:32','2024-05-24 14:57:32','72535889-eb2f-4eb5-9f8e-b26c55f5d6de'),(12147,12147,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:32','2024-05-24 14:57:32','ca938c3d-eee8-4422-b415-8a4706ba8568'),(12148,12148,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:32','2024-05-24 14:57:32','fb260808-327b-4f39-b540-14bb7efeb9ef'),(12149,12149,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:33','2024-05-24 14:57:33','5711dc4c-cfea-4267-9eb0-d3640ddd1d41'),(12150,12150,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:57:33','2024-05-24 14:57:33','568873e1-e64f-4b42-8d2e-ae0a951e6c0e'),(12151,12151,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:33','2024-05-24 14:57:33','eb94efa2-6171-4b6e-ad63-da4c87867358'),(12152,12152,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:57:33','2024-05-24 14:57:33','292774b4-0ebc-44ad-b7cb-963d95433b2b'),(12153,12153,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:33','2024-05-24 14:57:33','28289dfd-633c-4591-9fc9-337ad31ea045'),(12154,12154,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\"}',1,'2024-05-24 14:57:33','2024-05-24 14:57:33','649b1b78-f148-4c42-a5b7-695e188a3c1c'),(12155,12155,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:35','2024-05-24 14:57:35','79e9d8a2-1101-4bcf-9a9e-b01c86b420da'),(12156,12156,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:35','2024-05-24 14:57:35','7ec2bf0c-e6ba-4e21-bc08-1a96eae3b845'),(12157,12157,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:35','2024-05-24 14:57:35','86e07919-45f1-45ad-8950-604d0b4459d2'),(12158,12158,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:35','2024-05-24 14:57:35','2d6cc619-3ccc-408c-8789-917d81922ceb'),(12159,12159,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:38','2024-05-24 14:57:38','9362ae97-38fc-46b4-9268-78113d114ef1'),(12160,12160,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:38','2024-05-24 14:57:38','fe85eb3e-6557-4c16-bca8-2b73bce8f904'),(12161,12161,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:38','2024-05-24 14:57:38','7b0d1511-c419-4277-92f0-8ecc7d3a71ac'),(12162,12162,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:38','2024-05-24 14:57:38','70fd2bf1-9870-4850-aba0-12b7748c63d6'),(12163,12163,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:41','2024-05-24 14:57:41','40afc83c-240b-43eb-ab99-7403f90bca4d'),(12164,12164,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:41','2024-05-24 14:57:41','25324c20-fd7c-4a2a-8ee6-a097e418016d'),(12165,12165,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:41','2024-05-24 14:57:41','212ca26a-92d1-4026-82dd-54a12bdb6b9c'),(12166,12166,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:41','2024-05-24 14:57:41','39228311-07be-42ca-9124-92e781662d64'),(12167,12167,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:41','2024-05-24 14:57:41','b47ba31f-459e-45a4-b251-414d45286db8'),(12168,12168,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:57:41','2024-05-24 14:57:41','1efd2446-4594-4e79-86e4-1d696d7c7534'),(12169,12169,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:41','2024-05-24 14:57:41','46d3391a-b359-4685-9d99-c8be217ba8c8'),(12170,12170,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:57:41','2024-05-24 14:57:41','960695e3-0c9c-483c-a772-85e974fde903'),(12171,12171,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:41','2024-05-24 14:57:41','a4061f32-138e-4939-b056-c5be79fee06d'),(12172,12172,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\"}',1,'2024-05-24 14:57:41','2024-05-24 14:57:41','7000db9c-bc8d-4024-9751-602241f77e97'),(12173,12173,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:44','2024-05-24 14:57:44','bdfb2a28-cb77-430b-9a8d-669808a50844');
